Clinical Trials

Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions

Condition:   Healthy
Intervention:   Drug: Amlodipine Besylate / Benazepril Hydrochloride
Sponsor:   Dr. Reddy's Laboratories Limited
Completed

Fri, 02 Jul 2010 12:00:00 EDT

Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation

Condition:   Chronic Hypertension in Pregnancy
Intervention:   Drug: Amlodipine besylate
Sponsors:   University of Texas Southwestern Medical Center;   National Center for Advancing Translational Science (NCATS)
Completed

Tue, 03 Feb 2015 12:00:00 EST

Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions

Condition:   Healthy
Intervention:   Drug: Amlodipine Besylate / Benazepril Hydrochloride
Sponsor:   Dr. Reddy's Laboratories Limited
Completed

Fri, 02 Jul 2010 12:00:00 EDT

Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness

Condition:   Hypertension
Interventions:   Drug: Nifedipine GITS;   Drug: Amlodipine besylate
Sponsors:   Jing Liu;   Bayer
Unknown status

Fri, 21 Oct 2016 12:00:00 EDT

Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions

Condition:   Healthy
Intervention:   Drug: Amlodipine
Sponsor:   Dr. Reddy's Laboratories Limited
Completed

Thu, 27 May 2010 12:00:00 EDT

Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions

Condition:   Healthy
Intervention:   Drug: Amlodipine
Sponsor:   Dr. Reddy's Laboratories Limited
Completed

Thu, 27 May 2010 12:00:00 EDT

Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers

Condition:   Bioequivalence
Interventions:   Drug: LANDI-Amlodipine Besylate Tablet 5mg;   Drug: Norvasc Tablets 5mg
Sponsor:   Shanghai Haini Pharmaceutical Co., Ltd.
Completed

Mon, 28 Nov 2016 12:00:00 EST

Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension

Condition:   Arterial Hypertension
Intervention:   Combination Product: Fimasartan plus amlodipine besylate
Sponsor:   Centro Universitario de Ciencias de la Salud, Mexico
Unknown status

Tue, 26 Sep 2017 12:00:00 EDT

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

Condition:   Fed
Intervention:   Drug: Amlodipine Besylate/Benazepril HCl
Sponsor:   Dr. Reddy's Laboratories Limited
Completed

Mon, 09 Jan 2012 12:00:00 EST

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions

Condition:   Fasting
Intervention:   Drug: Amlodipine Besylate/Benazepril HCl
Sponsor:   Dr. Reddy's Laboratories Limited
Completed

Mon, 09 Jan 2012 12:00:00 EST

Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects

Condition:   Hypertension
Interventions:   Drug: Levamlodipine, Amlodipine;   Drug: Amlodipine, Levamlodipine
Sponsors:   Conjupro Biotherapeutics, Inc.;   CSPC Ouyi Pharmaceutical Co., Ltd.
Completed

Wed, 05 Sep 2018 12:00:00 EDT

Amlodipine 10mg Drug Use Investigation

Condition:   Hypertension
Intervention:   Drug: Amlodipine
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Fri, 03 Dec 2010 12:00:00 EST

Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition

Condition:   Healthy
Intervention:   Drug: Amlodipine besylate/Atorvastatin calcium
Sponsor:   Dr. Reddy's Laboratories Limited
Completed

Mon, 17 Nov 2014 12:00:00 EST

Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition

Condition:   Healthy
Intervention:   Drug: Amlodipine besylate/Atorvastatin calcium
Sponsor:   Dr. Reddy's Laboratories Limited
Completed

Wed, 19 Nov 2014 12:00:00 EST

Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations

Condition:   Healthy
Interventions:   Drug: BF-Amlodipine Tablet 10mg;   Drug: Norvasc Tablet 10mg
Sponsors:   Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited;   Chinese University of Hong Kong
Completed

Mon, 14 Mar 2016 12:00:00 EDT

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions

Condition:   Healthy
Interventions:   Drug: AMLODIPINE (as BESILATE) TABLETS 10 mg , single dose;   Drug: Norvasc® 10 mg Tablets
Sponsor:   Actavis Inc.
Completed

Fri, 27 Mar 2009 12:00:00 EDT

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions

Condition:   Healthy
Interventions:   Drug: AMLODIPINE (as BESILATE) TABLETS 10 mg , single dose;   Drug: NorvasC® 10 mg Tablets
Sponsor:   Actavis Inc.
Completed

Fri, 27 Mar 2009 12:00:00 EDT

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Condition:   Hypertension
Intervention:   Drug: Valsartan + Amlodipine besilate
Sponsor:   Novartis
Completed

Tue, 13 Mar 2007 12:00:00 EDT

CKD-330 Drug-Drug Interaction Study (Amlodipine)

Condition:   Hypertension
Interventions:   Drug: Amlodipine 10mg;   Drug: Amlodipine 10mg/Candesartan 32mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Mon, 17 Feb 2014 12:00:00 EST

Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index

Condition:   Frozen Embryo Transfer
Interventions:   Drug: Amlodipine 5mg;   Drug: Placebo
Sponsor:   University Hospital, Montpellier
Not yet recruiting

Thu, 08 Jul 2021 12:00:00 EDT

Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major

Conditions:   Thalassemia;   Iron Overload
Intervention:   Drug: Amlodipine
Sponsors:   University of Campinas, Brazil;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Completed

Fri, 15 Jul 2011 12:00:00 EDT

Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate

Condition:   Healthy
Intervention:   Drug: candesartan cilexetil 32mg, amlodipine 10mg
Sponsor:   HK inno.N Corporation
Unknown status

Fri, 03 May 2013 12:00:00 EDT

Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease

Condition:   Ischemic Heart Disease
Intervention:   Drug: Amlodipine
Sponsor:   Ruttonjee Hospital
Completed

Thu, 16 Sep 2010 12:00:00 EDT

Bedtime Administration of Amlodipine Versus Lisinopril

Condition:   Hypertension
Intervention:   Drug: Amlodipine
Sponsor:   Allina Health System
Unknown status

Fri, 19 Apr 2013 12:00:00 EDT

Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg

Condition:   Healthy
Intervention:   Drug: candesartan cilexetil 32mg, amlodipine 10mg
Sponsor:   Shin Poong Pharmaceutical Co. Ltd.
Completed

Wed, 21 Aug 2013 12:00:00 EDT

Amlodipine 10 mg Tablets Under Fed Conditions

Condition:   Healthy
Interventions:   Drug: Amlodipine Besylate;   Drug: Norvasc®
Sponsor:   Teva Pharmaceuticals USA
Completed

Wed, 11 Feb 2009 12:00:00 EST

Amlodipine 10 mg Tablets Under Fasting Conditions

Condition:   Healthy
Interventions:   Drug: Amlodipine Besylate;   Drug: Norvasc®
Sponsor:   Teva Pharmaceuticals USA
Completed

Wed, 11 Feb 2009 12:00:00 EST

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension

Condition:   Hypertension
Interventions:   Drug: amlodipine/losartan;   Drug: amlodipine
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Thu, 20 May 2010 12:00:00 EDT

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: S-amlodipine 2.5mg;   Drug: Amlodipine 5mg
Sponsors:   Ahn-Gook Pharmaceuticals Co.,Ltd;   Korea University Guro Hospital;   Dt&Sanomedics
Recruiting

Fri, 18 Sep 2020 12:00:00 EDT

Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients

Condition:   Female Infertility Associated With Anovulation
Interventions:   Drug: Clomifene citrate ( clomid 50 mg );   Drug: Amlodipine
Sponsor:   Ahmed Fathy Ali Mohamed Ghanem
Completed

Wed, 09 Sep 2015 12:00:00 EDT

Comparision of Blood Pressure Variability Between Amlodipine and Losartan

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: Losartan
Sponsors:   Wonju Severance Christian Hospital;   Pfizer
Completed

Thu, 17 Oct 2013 12:00:00 EDT

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

Condition:   Hypertension, Hyperlipidemia
Interventions:   Drug: Ezetimibe/Rosuvastatin;   Drug: Candesartan cilexetil/Amlodipine besylate;   Drug: Candesartan cilexetil
Sponsor:   HK inno.N Corporation
Active, not recruiting

Wed, 20 Feb 2019 12:00:00 EST

BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination

Condition:   Essential Hypertension
Intervention:   Drug: Fimasartan/Amlodipine
Sponsor:   Boryung Pharmaceutical Co., Ltd
Completed

Wed, 19 Jun 2019 12:00:00 EDT

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension

Condition:   Hypertension
Interventions:   Drug: Aliskiren/Amlodipine;   Drug: Amlodipine
Sponsor:   Novartis
Completed

Mon, 02 Mar 2009 12:00:00 EST

Manidipine Versus Amlodipine in Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: Manidipine 20mg;   Drug: Amlodipine 10mg
Sponsors:   Korea University Guro Hospital;   Takeda Pharmaceuticals International, Inc.
Terminated

Mon, 10 Apr 2017 12:00:00 EDT

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Condition:   Healthy
Interventions:   Drug: Amlodipine plus Losartan;   Drug: Amlodipine, Losartan
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Thu, 09 Sep 2010 12:00:00 EDT

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Condition:   Healthy
Interventions:   Drug: Amlodipine plus Losartan;   Drug: Amlodipine, Losartan
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Thu, 09 Sep 2010 12:00:00 EDT

Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

Condition:   Essential Hypertension
Intervention:   Drug: Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ
Sponsor:   Novartis
Completed

Thu, 29 Apr 2010 12:00:00 EDT

CKD-330 Phase 3 Trial in Amlodipine Non-responder

Condition:   Hypertension
Interventions:   Drug: CKD-330 16/5mg;   Drug: Amlodipine 5mg Placebo;   Drug: CKD-330 16/5mg Placebo;   Drug: Amlodipine 5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Mon, 26 Oct 2015 12:00:00 EDT

Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level

Condition:   Hypertension
Interventions:   Drug: valsartan (160 mg/d);   Drug: amlodipine (10 mg/d).
Sponsors:   Damanhour University;   Tanta University
Completed

Wed, 19 Jun 2019 12:00:00 EDT

Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan

Conditions:   Hypertension;   Diabetes Mellitus
Interventions:   Drug: Aliskiren;   Drug: Amlodipine
Sponsors:   Hospital Universitario Pedro Ernesto;   Novartis
Withdrawn

Thu, 04 Aug 2011 12:00:00 EDT

Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: TAH Tablet (Telmisartan80/Amlodipine besylate10/Hydrochlorothiazide12.5);   Drug: TWYNSTA(Telmisartan+Amlodipine besylate);   Drug: Hydrochlorothiazide
Sponsor:   IlDong Pharmaceutical Co Ltd
Completed

Thu, 26 Jan 2017 12:00:00 EST

Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: TAH Tablet (Telmisartan/Amlodipine besylate/Hydrochlorothiazide);   Drug: TWYNSTA(Telmisartan+Amlodipine besylate);   Drug: Hydrochlorothiazide
Sponsor:   IlDong Pharmaceutical Co Ltd
Completed

Fri, 15 Apr 2016 12:00:00 EDT

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension

Condition:   Hypertension
Interventions:   Drug: Aliskiren/Amlodipine;   Drug: Aliskiren/Amlodipine and Hydrochlorothiazide (HCTZ)
Sponsor:   Novartis
Completed

Tue, 21 Jul 2009 12:00:00 EDT

Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"

Condition:   Hypertension
Intervention:   Drug: Azilsartan/Amlodipine
Sponsor:   Takeda
Completed

Fri, 04 Jul 2014 12:00:00 EDT

Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Condition:   Essential Hypertension
Interventions:   Drug: Amlodipine-FA tablet,low dose group;   Drug: Amlodipine-FA tablet,high dose group;   Drug: Amlodipine
Sponsors:   Shenzhen Ausa Pharmed Co.,Ltd;   Ruijin Hospital;   Second Affiliated Hospital of Nanchang University;   Xuzhou Medical University
Unknown status

Tue, 08 Oct 2013 12:00:00 EDT

Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension

Condition:   Hypertension
Interventions:   Drug: Bisoprolol/Amlodipine (Bisoprolol failed group);   Drug: Bisoprolol/Amlodipine (Amlodipine failed group)
Sponsor:   Merck KGaA, Darmstadt, Germany
Completed

Thu, 07 Nov 2013 12:00:00 EST

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine plus Losartan;   Drug: Amlodipine
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Thu, 16 Jul 2009 12:00:00 EDT

China Stroke Primary Prevention Trial for Subjects With H-type Hypertension and MTHFR 677 CC/CT Genotype

Condition:   Hypertension
Interventions:   Drug: Amlodipine besylate tablets;   Drug: Amlodipine besylate and folic acid tablets
Sponsors:   Shenzhen Ausa Pharmed Co.,Ltd;   Shenzhen CCHRPP Biomedical Institute;   Peking University First Hospital;   Second Affiliated Hospital of Nanchang University;   The First People's Hospital of Lianyungang;   First Affiliated Hospital of Harbin Medical University;   The First Affiliated Hospital of Shanxi Medical University
Not yet recruiting

Fri, 23 Jul 2021 12:00:00 EDT

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone

Condition:   Hypertension
Interventions:   Drug: Amlodipine 10 mg;   Drug: Aliskiren 150;   Drug: Amlodipine 300
Sponsor:   Novartis
Completed

Fri, 24 Oct 2008 12:00:00 EDT

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: Valsartan/amlodipine 80/5 mg;   Drug: Amlodipine 5 mg
Sponsor:   Novartis
Completed

Tue, 19 Dec 2006 12:00:00 EST

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Condition:   Essential Hypertension
Interventions:   Drug: Amlodipine;   Drug: amlodipine-FA tablet, low dose group;   Drug: amlodipine-FA tablet ,high dose group
Sponsors:   Shenzhen Ausa Pharmed Co.,Ltd;   Peking University First Hospital;   Chinese PLA General Hospital;   Capital Medical University;   Fudan University;   Ruijin Hospital;   Nanchang University;   First Affiliated Hospital of Fujian Medical University;   First Affiliated Hospital of Harbin Medical University;   China Medical University, China;   Health Science Center of Xi'an Jiaotong University;   Xuzhou Medical University;   Anhui Medical University;   Huazhong University of Science and Technology;   West China Hospital;   Guangdong Provincial People's Hospital;   Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown status

Wed, 08 May 2013 12:00:00 EDT

Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina

Condition:   Quality of Life
Interventions:   Drug: Caduet 10Mg-20Mg Tablet;   Drug: NorvasC® 10 mg Tablets
Sponsor:   Kosin University Gospel Hospital
Unknown status

Wed, 15 Feb 2017 12:00:00 EST

Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: hydrochlorothiazide;   Drug: Aliskiren
Sponsor:   Novartis
Completed

Tue, 25 Nov 2008 12:00:00 EST

Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity

Condition:   Coronary Artery Disease
Interventions:   Drug: Ranolazine;   Drug: Amlodipine
Sponsor:   University of Roma La Sapienza
Unknown status

Mon, 12 Dec 2011 12:00:00 EST

A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension

Condition:   Hypertension
Intervention:   Drug: Fimasartan , Amlodipine, Placebo
Sponsors:   Boryung Pharmaceutical Co., Ltd;   Gachon University Gil Medical Center;   The Catholic University of Korea;   Kyungpook National University Hospital;   Daegu Catholic University Medical Center;   Wonkwang University Hospital;   Wonju Severance Christian Hospital;   Korea University Guro Hospital;   DongGuk University;   Yeungnam University Hospital;   Chonnam National University Hospital;   Cheil General Hospital and Women's Healthcare Center;   Chungnam National University;   Asan Medical Center;   Seoul National University Bundang Hospital;   Inha University Hospital;   Seoul National University Hospital;   Inje University;   Samsung Medical Center;   Busan National University Yangsan Hospital;   Soon Chun Hyang University;   Catholic University of Korea Saint Paul's Hospital;   Hallym University Kangnam Sacred Heart Hospital;   Jeju National University Hospital;   Hanyang University Seoul Hospital;   Kangbuk Samsung Hospital
Completed

Thu, 26 Jan 2012 12:00:00 EST

Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules

Condition:   Healthy Volunteers
Interventions:   Drug: Amlodipine - reference;   Drug: Amlodipine ODT - test
Sponsors:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.;   Aurobindo Pharma Ltd;   Trident Life Sciences Ltd.
Completed

Fri, 06 Aug 2010 12:00:00 EDT

S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: S-amlodipine 2.5mg + Chlorthalidone 25mg;   Drug: S-amlodipine 2.5mg + Telmisartan 40mg
Sponsors:   Seoul National University Bundang Hospital;   Hanlim Pharm. Co., Ltd.
Unknown status

Fri, 21 Jul 2017 12:00:00 EDT

A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy Volunteers

Condition:   HIV
Interventions:   Drug: Raltegravir;   Drug: Amlodipine
Sponsor:   St Stephens Aids Trust
Completed

Fri, 26 Apr 2013 12:00:00 EDT

Drug-drug Interaction Study(CKD-501, Amlodipine)

Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: CKD-501;   Drug: amlodiopine;   Drug: CKD-501 amlodipine
Sponsors:   Chong Kun Dang Pharmaceutical;   Severance Hospital
Completed

Mon, 25 Apr 2011 12:00:00 EDT

Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis

Conditions:   Hemodialysis;   Pharmacokinetics
Intervention:   Drug: Amlodipine Besylate
Sponsor:   University of Michigan
Withdrawn

Fri, 26 Oct 2018 12:00:00 EDT

Telmisartan, Amlodipine and Combination in Healthy Subjects

Condition:   Healthy
Intervention:   Drug: amlodipine/telmisartan/combination
Sponsor:   Boehringer Ingelheim
Completed

Fri, 13 Aug 2010 12:00:00 EDT

Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

Condition:   Moderate to Severe Hypertension
Interventions:   Drug: Aliskiren/amlodipine 300/10 mg tablet;   Drug: Amlodipine 10 mg capsule
Sponsor:   Novartis
Completed

Wed, 11 Feb 2009 12:00:00 EST

CKD-828 Drug Interaction Study (S-amlodipine)

Condition:   Healthy Male Volunteers
Interventions:   Drug: S-amlodipine 5mg,Telmisartan 80mg;   Drug: S-amlodipine 5mg
Sponsors:   Chong Kun Dang Pharmaceutical;   Asan Medical Center
Completed

Thu, 19 May 2011 12:00:00 EDT

The Pharmacokinetic Interaction Between Amlodipine and Losartan

Condition:   Healthy
Interventions:   Drug: Amlodipine10mg;   Drug: Losartan potassium 100mg;   Drug: Amlodipine plus Losartan
Sponsors:   Korea University Anam Hospital;   Hanmi Pharmaceutical co., ltd.
Completed

Thu, 11 Apr 2019 12:00:00 EDT

Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: Azilsartan Medoxomil and amlodipine;   Drug: Amlodipine
Sponsor:   Takeda
Completed

Fri, 11 Jan 2008 12:00:00 EST

A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient

Condition:   Hypertension
Intervention:   Drug: Amlodipine
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Mon, 25 Dec 2006 12:00:00 EST

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

Condition:   Essential Hypertension
Interventions:   Drug: Candesartan cilexetil 16mg;   Drug: Amlodipine 10mg, Candesartan cilexetil 16mg
Sponsor:   HK inno.N Corporation
Unknown status

Mon, 23 Feb 2015 12:00:00 EST

Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives

Condition:   Hypertension
Interventions:   Drug: OE 10 mg amlodipine besylate tablet;   Drug: OE 200 mg celecoxib capsule;   Drug: Matched placebo for OE amlodipine besylate tablet;   Drug: Matched placebo for OE celecoxib capsule
Sponsor:   Kitov Pharma Ltd
Completed

Thu, 01 Dec 2016 12:00:00 EST

Amlodipine Plus/Minus Atorvastatin for Protection of Arteries

Condition:   Arterial and Arteriolar Disorders
Interventions:   Drug: amlodipine plus atorvastatin (Caduet);   Drug: amlodipine (Norvasc)
Sponsor:   Shanghai Institute of Hypertension
Unknown status

Wed, 14 Aug 2013 12:00:00 EDT

Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients

Condition:   Hypertension
Intervention:   Drug: aliskiren/amlodipine
Sponsor:   University of Pavia
Unknown status

Wed, 13 Jan 2010 12:00:00 EST

Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major

Condition:   Thalassemia Major
Intervention:   Drug: Amlodipine
Sponsors:   University of Campinas, Brazil;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Completed

Tue, 18 May 2010 12:00:00 EDT

The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)

Condition:   Ischemic Stroke
Interventions:   Drug: losartan;   Drug: amlodipine
Sponsor:   Taipei Veterans General Hospital, Taiwan
Completed

Thu, 18 Sep 2008 12:00:00 EDT

A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients

Condition:   Coronary Artery Disease
Interventions:   Drug: Placebo;   Drug: Amlodipine
Sponsor:   Seoul National University Hospital
Unknown status

Mon, 10 May 2010 12:00:00 EDT

Perindopril Amlodipine for the Treatment of Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: XOMA 985;   Drug: Amlodipine Besylate;   Drug: Perindopril Erbumine
Sponsor:   Symplmed Pharmaceuticals LLC
Completed

Mon, 19 Mar 2012 12:00:00 EDT

Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension

Conditions:   Hypertension;   Ankle Edema
Interventions:   Drug: Aliskiren/amlodipine;   Drug: Amlodipine;   Drug: Placebo to Aliskiren/amlodipine;   Drug: Placebo to Amlodipine
Sponsor:   Novartis Pharmaceuticals
Terminated

Thu, 04 Mar 2010 12:00:00 EST

Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions

Condition:   Healthy
Intervention:   Drug: amlodipine 10 mg tablet
Sponsor:   Ranbaxy Laboratories Limited
Completed

Mon, 20 Oct 2008 12:00:00 EDT

Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension

Conditions:   Hypertension;   Abdominal Aortic Aneurysm
Interventions:   Drug: Aliskiren;   Drug: Amlodipine
Sponsors:   VU University Medical Center;   Novartis
Terminated

Mon, 29 Aug 2011 12:00:00 EDT

Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan/Amlodipine;   Drug: Telmisartan;   Drug: Amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Thu, 09 Oct 2014 12:00:00 EDT

Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan;   Drug: Amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Thu, 09 Oct 2014 12:00:00 EDT

Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions

Condition:   Healthy
Intervention:   Drug: amlodipine 10 mg tablet
Sponsor:   Ranbaxy Laboratories Limited
Completed

Mon, 20 Oct 2008 12:00:00 EDT

Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.

Conditions:   Hypertension;   Left Ventricular Hypertrophy
Interventions:   Drug: sacubitril/valsartan;   Drug: Amlodipine
Sponsor:   Shanghai Jiao Tong University School of Medicine
Not yet recruiting

Fri, 18 Jun 2021 12:00:00 EDT

Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial

Condition:   Essential Hypertension
Intervention:   Drug: Valsartan, Amlodipine -
Sponsor:   PharmEvo Pvt Ltd
Completed

Wed, 13 Dec 2017 12:00:00 EST

Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy

Condition:   Hypertension
Interventions:   Drug: irbesartan/amlodipine;   Drug: amlodipine
Sponsor:   Sanofi
Completed

Tue, 11 Aug 2009 12:00:00 EDT

Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy

Condition:   Hypertension
Interventions:   Drug: Over-encapsulated 10 mg amlodipine besylate tablet;   Drug: Matched placebo capsule for over-encapsulated celecoxib capsule;   Drug: Over-encapsulated 200 mg celecoxib capsule;   Drug: Matched placebo capsule for over-encapsulated amlodipine besylate tablet
Sponsor:   Kitov Pharmaceuticals, Ltd.
Completed

Tue, 24 Jun 2014 12:00:00 EDT

The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

Conditions:   Hypertension;   Diastolic Dysfunction
Interventions:   Drug: valsartan;   Drug: amlodipine
Sponsor:   Novartis Pharmaceuticals
Completed

Fri, 31 Aug 2007 12:00:00 EDT

Fimasartan/Amlodipine Combination Phase III

Condition:   Essential Hypertension
Interventions:   Drug: Fimasartan and Amlodipine;   Drug: Fimasartan
Sponsors:   Boryung Pharmaceutical Co., Ltd;   Gachon University Gil Medical Center;   The Catholic University of Korea;   Kangbuk Samsung Hospital;   Kyungpook National University Hospital;   Keimyung University Dongsan Medical Center;   Korea University Guro Hospital;   Korea University Anam Hospital;   DongGuk University;   Dong-A University Hospital;   Pusan National University Hospital;   Seoul National University Bundang Hospital;   Seoul National University Hospital;   Asan Medical Center;   Pusan National University Yangsan Hospital;   Wonju Severance Christian Hospital;   Gangnam Severance Hospital;   Severance Hospital;   Ulsan University Hospital;   Inje University;   Inje University Haeundai Paik Hospital;   Chonnam National University Hospital;   Jeju National University Hospital;   Chungnam National University;   Hanyang University Seoul Hospital
Completed

Mon, 02 Jun 2014 12:00:00 EDT

Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.

Condition:   Hypertension, Renal
Interventions:   Drug: Bisoprolol Fumarate 5-10 mg;   Drug: Amlodipine 5-10 mg
Sponsors:   Alexandria University;   Damanhour University
Completed

Wed, 11 Sep 2019 12:00:00 EDT

Telmisartan and Amlodipine Versus Monocomponent Tablets

Condition:   Hypertension
Interventions:   Drug: Telmisartan/Amlodipine Combination Tablet;   Drug: Amlodipine Monocomponent
Sponsor:   Boehringer Ingelheim
Completed

Wed, 19 Jan 2011 12:00:00 EST

Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients

Condition:   Essential Hypertension
Interventions:   Drug: Telmisartan/Amlodipine+Hydrochlorothiazide;   Drug: Telmisartan/Amlodipine;   Drug: Placebo for Hydrochlorothiazide
Sponsor:   IlDong Pharmaceutical Co Ltd
Completed

Thu, 14 Apr 2016 12:00:00 EDT

Bariatric Surgery and Pharmacokinetics of Amlodipine

Condition:   Obesity, Morbid
Intervention:   Drug: Amlodipine
Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Volvat Medisinsk Senter Stokkan;   Namsos Hospital;   Alesund Hospital
Recruiting

Fri, 16 Sep 2016 12:00:00 EDT

Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension

Condition:   Hypertension
Intervention:   Drug: amlodipine besylate/benazepril hydrochloride
Sponsor:   Novartis Pharmaceuticals
Completed

Mon, 29 Aug 2005 12:00:00 EDT

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus

Conditions:   Hypertension;   Diabetes Mellitus
Interventions:   Drug: Amlodipine;   Drug: Hydrochlorothiazide (HCTZ);   Drug: Aliskiren
Sponsor:   Novartis
Completed

Fri, 07 Nov 2008 12:00:00 EST

Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

Conditions:   Beta-Thalassemia;   Iron Overload
Interventions:   Drug: Amlodipine;   Drug: Deferasirox
Sponsor:   Kevin H.M. Kuo, MD, MSc, FRCPC
Unknown status

Wed, 17 Jun 2015 12:00:00 EDT

Treatment of Early Hypertension Among Persons Living With HIV in Haiti

Conditions:   HIV/AIDS;   Pre Hypertension
Intervention:   Drug: Amlodipine 5mg
Sponsors:   Weill Medical College of Cornell University;   Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic;   Fogarty International Center of the National Institute of Health
Recruiting

Thu, 31 Dec 2020 12:00:00 EST

Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)

Condition:   Hypertension
Interventions:   Drug: HL068 16/10mg;   Drug: Candesartan 16mg and Amlodipine 10mg
Sponsor:   HanAll BioPharma Co., Ltd.
Unknown status

Fri, 09 Dec 2016 12:00:00 EST

Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients

Condition:   Hypertension
Intervention:   Drug: S-NOR (s-amlodipine) 2,5 mg & 5 mg tablet
Sponsor:   Neutec Ar-Ge San ve Tic A.Ş
Completed

Tue, 31 Jan 2017 12:00:00 EST

Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients

Conditions:   Hypertension;   Dialysis
Intervention:   Drug: Aliskiren
Sponsors:   University of Campania "Luigi Vanvitelli";   IRCCS San Raffaele
Unknown status

Thu, 14 Jul 2011 12:00:00 EDT

Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus

Condition:   Hypertension
Interventions:   Drug: Telmisartan 80;   Drug: Amlodipine 10
Sponsor:   Boehringer Ingelheim
Completed

Wed, 08 Apr 2009 12:00:00 EDT

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

Condition:   Primary Hypertension
Intervention:   Drug: valsartan/amlodipine
Sponsor:   Novartis
Completed

Tue, 16 Nov 2010 12:00:00 EST

Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension

Condition:   Hypertension
Interventions:   Drug: Losartan and Amlodipine;   Drug: Losartan
Sponsor:   Centro Universitario de Ciencias de la Salud, Mexico
Unknown status

Fri, 10 Aug 2018 12:00:00 EDT

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Conditions:   Type 2 Diabetes;   Hypertension
Interventions:   Drug: Amlodipine;   Drug: amlodipine / olmesartan medoxomil combination;   Drug: Hydrochlorothiazide
Sponsor:   Daiichi Sankyo, Inc.
Completed

Wed, 09 Apr 2008 12:00:00 EDT

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

Condition:   Essential Hypertension
Intervention:   Drug: Amlodipine/Valsartan
Sponsor:   TSH Biopharm Corporation Limited
Completed

Mon, 10 Feb 2014 12:00:00 EST

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

Condition:   Essential Hypertension
Interventions:   Drug: Amlodipine 5mg;   Drug: Amlodipine 5mg, Candesartan cilexetil 16mg;   Drug: Amlodipine 10mg, Candesartan cilexetil 16mg
Sponsor:   HK inno.N Corporation
Unknown status

Mon, 23 Feb 2015 12:00:00 EST

Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension

Condition:   Hypertension in Pregnancy
Interventions:   Drug: Amlodipine;   Drug: NIFEdipine ER
Sponsor:   Prisma Health-Upstate
Recruiting

Wed, 10 Mar 2021 12:00:00 EST

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

Condition:   Stage 2 Systolic Hypertension
Interventions:   Drug: valsartan, amlodipine, HCTZ;   Drug: Losartan, HCTZ followed by valsartan, amlodipine, HCTZ
Sponsor:   Novartis
Completed

Thu, 02 Jul 2009 12:00:00 EDT

Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Participants

Condition:   Healthy
Interventions:   Drug: Bisoprolol-Amlodipine FDC;   Drug: Bisoprolol;   Drug: Amlodipine
Sponsor:   Merck KGaA, Darmstadt, Germany
Completed

Fri, 21 Jul 2017 12:00:00 EDT

A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland)

Condition:   Healthy
Intervention:   Drug: Valsartan and Amlodipine Tablets
Sponsor:   Second Affiliated Hospital of Wenzhou Medical University
Unknown status

Wed, 11 Sep 2019 12:00:00 EDT

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: Olmesartan medoxomil;   Drug: Amlodipine+valsartan;   Drug: Hydrochlorothiazide
Sponsor:   Novartis
Completed

Fri, 31 Aug 2007 12:00:00 EDT

Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine plus Losartan;   Drug: Losartan
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Thu, 16 Jul 2009 12:00:00 EDT

China Stroke Primary Prevention Trial for Subjects With Hypertension and MTHFR 677 TT Genotype (CSPPT2-TT)

Condition:   Hypertension
Interventions:   Drug: Amlodipine besylate tablets;   Drug: Amlodipine besylate And Folic Acid Tablets;   Drug: Folic Acid Tablets
Sponsors:   Shenzhen Ausa Pharmed Co.,Ltd;   Shenzhen CCHRPP Biomedical Institute;   Peking University First Hospital;   Second Affiliated Hospital of Nanchang University;   The First People's Hospital of Lianyungang;   First Affiliated Hospital of Harbin Medical University;   The First Affiliated Hospital of Shanxi Medical University
Not yet recruiting

Fri, 23 Jul 2021 12:00:00 EDT

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Conditions:   Hypertension;   Angina Pectoris;   Hypercholesterolemia;   Familial Hypercholesterolemia
Intervention:   Drug: Amlodipine/Atorvastatin
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Wed, 21 Apr 2010 12:00:00 EDT

Amlodipine for Myocardial Iron in Thalassemia

Condition:   Thalassemia
Interventions:   Drug: Standard Chelation;   Drug: Amlodipine
Sponsor:   Aga Khan University
Completed

Wed, 19 Feb 2014 12:00:00 EST

Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia

Conditions:   Essential Hypertension;   Dyslipidemia
Interventions:   Drug: Fimasartan/Amlodipine, Rosuvastatin;   Drug: Fimasartan/Amlodipine;   Drug: Fimasartan, Rosuvastatin
Sponsor:   Boryung Pharmaceutical Co., Ltd
Completed

Wed, 17 May 2017 12:00:00 EDT

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: Valsartan/Amlodipine;   Drug: Nifedipine
Sponsor:   Novartis
Completed

Thu, 22 Jul 2010 12:00:00 EDT

Amlodipine Prevents Morning Blood Pressure Surge Study

Condition:   Hypertension
Interventions:   Drug: Amlodipine (Norvasc®);   Drug: Nifedipine GITS (Adalat® XL 30
Sponsor:   Shanghai Jiao Tong University School of Medicine
Completed

Fri, 11 Dec 2009 12:00:00 EST

Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: Valsartan
Sponsors:   Asan Medical Center;   Yuhan Corporation
Completed

Fri, 25 Nov 2016 12:00:00 EST

Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

Condition:   Hypertension
Interventions:   Drug: Reference Treatment: 5 mg amlodipine + 50 mg losartan;   Drug: Reference Treatment:5 mg amlodipine + 100 mg losartan;   Drug: FDC 5/50 amlodipine/ losartan;   Drug: FDC 5/100 amlodipine /losartan
Sponsor:   GlaxoSmithKline
Completed

Mon, 25 Feb 2013 12:00:00 EST

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone

Condition:   Hypertension
Interventions:   Drug: Aliskiren 300 mg;   Drug: Aliskiren/Amlodipine 300/5 mg;   Drug: Aliskiren/Amlodipine 300/10 mg;   Drug: Placebo to Aliskiren;   Drug: Placebo to Aliskiren/Amlodipine
Sponsor:   Novartis
Completed

Wed, 22 Oct 2008 12:00:00 EDT

Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension

Condition:   Stage II Hypertension
Intervention:   Drug: Aliskiren/Amlodipine (150/5 mg/day, 300/10 mg/day) , Aliskiren/Amlodipine/Hydrochlorothiazide (300/10/12.5 mg/day, 300/10/25 mg/day)
Sponsor:   Novartis
Completed

Wed, 17 Feb 2010 12:00:00 EST

Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension

Condition:   Hypertension
Interventions:   Drug: amlodipine;   Drug: telmisartan;   Drug: telmisartan and amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Thu, 12 Mar 2009 12:00:00 EDT

Anti Inflammatory Treatment of Hypertension

Condition:   Hypertension
Interventions:   Drug: Levamlodipine;   Drug: Amlodipine
Sponsors:   Affiliated Hospital of North Sichuan Medical College;   First Hospitals affiliated to the China PLA General Hospital
Completed

Fri, 05 Feb 2021 12:00:00 EST

Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects

Conditions:   Hypertension;   Concurrent Obesity
Interventions:   Drug: LCZ696;   Drug: amlodipine;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed

Fri, 29 Jun 2012 12:00:00 EDT

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

Conditions:   Essential Hypertension;   Hyperlipidemia
Interventions:   Drug: Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg;   Drug: Telmisartan 80mg and S-amlodipine 5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Mon, 29 Apr 2013 12:00:00 EDT

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers

Condition:   Hypertension With Dyslipidemia
Interventions:   Drug: JLP-1401;   Drug: Telmisartan/Amlodipine, Rosuvastatin
Sponsor:   Jeil Pharmaceutical Co., Ltd.
Completed

Tue, 16 Oct 2018 12:00:00 EDT

An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

Condition:   Hypertension
Interventions:   Drug: Aliskiren;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
Sponsor:   Novartis
Completed

Wed, 22 Nov 2006 12:00:00 EST

To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

Conditions:   Hypertension;   High Blood Pressure
Interventions:   Drug: Amlodipine 5mg/Valsartan 80 mg;   Drug: Valsartan
Sponsor:   Novartis
Completed

Wed, 17 Feb 2010 12:00:00 EST

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Condition:   Essential Hypertension
Intervention:   Drug: amlodipine/valsartan
Sponsor:   Novartis Pharmaceuticals
Completed

Fri, 14 Feb 2014 12:00:00 EST

Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

Condition:   Hypertension
Interventions:   Drug: Losartan (+) amlodipine;   Drug: Placebo to match losartan/amlodipine tablets;   Drug: Amlodipine camsylate;   Drug: Placebo to match amlodipine
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Mon, 17 Jan 2011 12:00:00 EST

The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers

Condition:   Hypertension With Dyslipidemia
Interventions:   Drug: JLP-1401;   Drug: Telmisartan/Amlodipine, Rosuvastatin
Sponsor:   Jeil Pharmaceutical Co., Ltd.
Completed

Fri, 11 Aug 2017 12:00:00 EDT

Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan

Condition:   Hypertension
Interventions:   Drug: Group I;   Drug: Group II
Sponsor:   HK inno.N Corporation
Unknown status

Thu, 27 Jul 2017 12:00:00 EDT

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: TCV-116CCB;   Drug: Amlodipine Placebo;   Drug: TCV-116CCB Placebo
Sponsor:   Takeda
Withdrawn

Mon, 21 Nov 2016 12:00:00 EST

Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine

Condition:   Essential Hypertension
Interventions:   Drug: LCZ696;   Drug: Amlodipine;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed

Mon, 13 Aug 2012 12:00:00 EDT

Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 18 Fed, Healthy Adult Subjects

Condition:   Healthy
Interventions:   Drug: Amlodipine Besylate;   Drug: Norvasc
Sponsor:   Torrent Pharmaceuticals Limited
Completed

Fri, 03 Jul 2009 12:00:00 EDT

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

Conditions:   Diabetes Mellitus, Type 2;   Hypertension
Interventions:   Drug: Perindopril and Amlodipine;   Drug: Perindopril-indapamide
Sponsors:   Yaounde Central Hospital;   University of Yaounde 1
Completed

Tue, 20 Nov 2018 12:00:00 EST

Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects

Condition:   Healthy
Interventions:   Drug: Amlodipine besylate;   Drug: Norvasc
Sponsor:   Torrent Pharmaceuticals Limited
Completed

Fri, 03 Jul 2009 12:00:00 EDT

Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Levamlodipine besylate;   Drug: Amlodipine maleate
Sponsor:   Jiangsu Simcere Pharmaceutical Co., Ltd.
Completed

Thu, 27 May 2010 12:00:00 EDT

Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension

Condition:   Hypertension
Intervention:   Drug: statin, amlodipine
Sponsor:   Gachon University Gil Medical Center
Completed

Tue, 26 Aug 2008 12:00:00 EDT

Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia

Condition:   Beta Thalassemia Major
Interventions:   Drug: Spirulina;   Drug: Amlodipine
Sponsor:   Tanta University
Completed

Tue, 02 Feb 2016 12:00:00 EST

Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

Condition:   Hypertension
Interventions:   Drug: Perindopril + amlodipine + if necessary, hydrochlorothiazide;   Drug: olmesartan/amlodipine + hydrochlorothiazide, if necessary.
Sponsor:   Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Completed

Fri, 09 Apr 2010 12:00:00 EDT

Telmisartan+Amlodipine Fixed Dose Combination in Hypertension

Condition:   Hypertension
Intervention:   Drug: telmisartan+amlodipine fixed dose combination
Sponsor:   Boehringer Ingelheim
Completed

Fri, 17 Sep 2010 12:00:00 EDT

CKD-828 S-Amlodipine Non-Responder Trial

Condition:   Hypertension
Interventions:   Drug: CKD-828 2.5/40mg;   Drug: CKD-828 2.5/80mg;   Drug: S-Amlodipine 2.5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Thu, 29 Dec 2011 12:00:00 EST

Fixed vs Free Dose of ACEi/CCB Combination Therapy

Condition:   Hypertension
Intervention:   Drug: Perindopril/Amlodipine
Sponsor:   Guido Iaccarino
Completed

Mon, 19 Dec 2016 12:00:00 EST

Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome

Conditions:   High Blood Pressure;   Metabolic Syndrome;   Insulin Resistance;   Endothelial Dysfunction
Interventions:   Drug: Aliskiren;   Drug: Amlodipine;   Drug: Placebo Aliskiren;   Drug: Placebo Amlodipine
Sponsor:   Novartis Pharmaceuticals
Completed

Fri, 29 Dec 2006 12:00:00 EST

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Amlodipine 5mg;   Drug: Amlodipine 10mg;   Drug: Candesartan Cilexetil 8mg;   Drug: Candesartan cilexetil 16mg
Sponsor:   HK inno.N Corporation
Unknown status

Tue, 11 Feb 2014 12:00:00 EST

Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome

Conditions:   Sleep Apnea Syndrome;   Hypertension
Interventions:   Drug: Amlodipine;   Drug: metoprolol
Sponsor:   First Affiliated Hospital of Harbin Medical University
Unknown status

Fri, 03 Apr 2015 12:00:00 EDT

Calcium Channel Blockade in Primary Aldosteronism

Conditions:   Primary Aldosteronism;   Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Intervention:   Drug: Amlodipine
Sponsors:   Brigham and Women's Hospital;   University of Michigan
Recruiting

Tue, 26 Nov 2019 12:00:00 EST

Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate Tablets

Condition:   Healthy Volunteers
Interventions:   Drug: Amlodipine - reference;   Drug: Amlodipine ODT - test
Sponsors:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.;   Aurobindo Pharma Ltd;   Trident Life Sciences Ltd.
Completed

Mon, 07 Jun 2010 12:00:00 EDT

Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers

Condition:   Hypertension With Hyperlipidemia
Intervention:   Drug: telmisartan/amlodipine and atorvastatin
Sponsor:   Jeil Pharmaceutical Co., Ltd.
Completed

Fri, 09 Mar 2018 12:00:00 EST

Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient

Condition:   Hypertension
Intervention:   Drug: Amlodipine
Sponsor:   Pfizer
Completed

Tue, 06 Mar 2007 12:00:00 EST

Irbesartan Versus Amlodipine: The OBI Study

Conditions:   Obesity;   Hypertension
Interventions:   Drug: Irbesartan;   Drug: Amlodipine
Sponsor:   Aristotle University Of Thessaloniki
Withdrawn

Thu, 01 Oct 2009 12:00:00 EDT

A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

Condition:   Healthy
Interventions:   Drug: Amlodipine/Valsartan;   Drug: Exforge
Sponsors:   Genuine Research Center, Egypt;   Pharmacare PLC, Palestine
Completed

Mon, 10 Aug 2015 12:00:00 EDT

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

Condition:   Hypertension
Interventions:   Drug: Candesartan32mg;   Drug: Amlodipine10mg
Sponsor:   HanAll BioPharma Co., Ltd.
Completed

Thu, 07 Mar 2013 12:00:00 EST

Bioequivalence Study of CJ-30059

Condition:   Healthy Volunteers
Interventions:   Drug: Candesartan cilexetil 16 mg and Amlodipine besylate 10mg (Reference);   Drug: CJ-30059 (Test)
Sponsor:   HK inno.N Corporation
Unknown status

Wed, 25 Jun 2014 12:00:00 EDT

Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

Condition:   Drug-Drug Interaction
Intervention:   Drug: Fimasartan/Amlodipine combination drug, Hydrochlorothiazide
Sponsor:   Boryung Pharmaceutical Co., Ltd
Completed

Thu, 04 Jan 2018 12:00:00 EST

TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

Condition:   Hypertension
Intervention:   Drug: telmisartan/amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Wed, 02 Jun 2010 12:00:00 EDT

Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans

Condition:   Hypertension
Interventions:   Drug: Aliskiren Hydrochlorothiazide (HCTZ): 8 weeks;   Drug: Amlodipine: 8 weeks
Sponsor:   Novartis Pharmaceuticals
Completed

Fri, 22 Aug 2008 12:00:00 EDT

Bioequivalency Study of Amlodipine Tablets Under Fed Conditions

Conditions:   Hypertension;   Chronic Stable Angina;   Vasospastic Angina
Intervention:   Drug: Amlodipine
Sponsor:   Roxane Laboratories
Completed

Mon, 28 Jan 2008 12:00:00 EST

Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions

Conditions:   Hypertension;   Chronic Stable Angina;   Vasospastic Angina
Intervention:   Drug: Amlodipine
Sponsor:   Roxane Laboratories
Completed

Mon, 28 Jan 2008 12:00:00 EST

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions

Condition:   Healthy
Interventions:   Drug: Amlodipine-benazepril 10 mg-20 mg capsules;   Drug: Lotrel® 10 mg-20 mg capsule
Sponsor:   Teva Pharmaceuticals USA
Completed

Tue, 03 Feb 2009 12:00:00 EST

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

Condition:   Healthy
Interventions:   Drug: Amlodipine-benazepril 10 mg-20 mg capsules;   Drug: Lotrel® 10 mg-20 mg capsule
Sponsor:   Teva Pharmaceuticals USA
Completed

Tue, 03 Feb 2009 12:00:00 EST

The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

Condition:   Hypertension
Intervention:   Drug: valsartan and amlodipine
Sponsor:   Novartis
Completed

Fri, 25 Apr 2008 12:00:00 EDT

Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

Conditions:   Hypertension;   Abdominal Obesity
Interventions:   Drug: Aliskiren;   Drug: Amlodipine;   Drug: Placebo of Aliskiren;   Drug: Placebo of amlodipine
Sponsor:   Novartis
Terminated

Tue, 10 Jul 2007 12:00:00 EDT

A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives

Conditions:   Obesity;   Hypertension
Interventions:   Drug: eplerenone, amlodipine;   Drug: eplerenone;   Drug: amlodipine
Sponsor:   University of Mississippi Medical Center
Terminated

Mon, 19 Jan 2009 12:00:00 EST

Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: Valsartan/amlodipine 80/5 mg;   Drug: Valsartan 80 mg;   Drug: Valsartan 160 mg
Sponsor:   Novartis Pharmaceuticals
Completed

Tue, 19 Dec 2006 12:00:00 EST

Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus

Condition:   Hypertension
Intervention:   Drug: Amlodipine/benazepril
Sponsor:   Novartis
Completed

Thu, 24 Aug 2006 12:00:00 EDT

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

Conditions:   Dyslipidemias;   Hypertension
Interventions:   Drug: Rosuampin 10/5mg;   Drug: Rosuampin 20/5mg;   Drug: Amlodipine/Atorvastatin 5/20mg
Sponsor:   Yuhan Corporation
Recruiting

Wed, 15 May 2019 12:00:00 EDT

Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin

Condition:   Healthy Volunteers
Intervention:   Drug: Candesartan, Amlodipine, Atorvastatin
Sponsor:   Midas Pharma GmbH
Completed

Tue, 28 Jan 2020 12:00:00 EST

CKD-330 Drug-Drug Interaction Study (Candesartan)

Condition:   Hypertension
Interventions:   Drug: Candesartan 32mg;   Drug: Candesartan 32mg/Amlodipine 10mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Mon, 17 Feb 2014 12:00:00 EST

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B

Condition:   Hypertension
Interventions:   Drug: CKD-330 16/5mg - B;   Drug: Candesartan 16mg and Amlodipine 5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Thu, 23 Jun 2016 12:00:00 EDT

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A

Condition:   Hypertension
Interventions:   Drug: CKD-330 16/5mg - A;   Drug: Candesartan 16mg and Amlodipine 5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Thu, 16 Jun 2016 12:00:00 EDT

Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Valsartan 160 mg capsules;   Drug: Amlodipine 5 mg capsules;   Drug: placebo
Sponsor:   Novartis Pharmaceuticals
Completed

Wed, 21 Feb 2007 12:00:00 EST

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Candesartan Cilexetil 8mg;   Drug: Candesartan Cilexetil 16mg;   Drug: Amlodipine 5mg;   Drug: Amlodipine 10mg
Sponsor:   Shin Poong Pharmaceutical Co. Ltd.
Completed

Wed, 26 Oct 2016 12:00:00 EDT

Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome

Condition:   Hypertension With Metabolic Syndrome
Interventions:   Drug: Amlodipine;   Drug: Aliskiren;   Drug: Ramipril
Sponsor:   Novartis
Terminated

Thu, 11 Oct 2007 12:00:00 EDT

One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension

Condition:   Hypertension
Intervention:   Drug: valsartan+amlodipine
Sponsor:   Novartis
Completed

Mon, 11 Dec 2006 12:00:00 EST

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Condition:   Hypertension
Interventions:   Drug: Candesartan 16mg;   Drug: Amlodipine 5mg;   Drug: Amlodipine 10mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Mon, 11 Jan 2016 12:00:00 EST

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Condition:   Hypertension
Intervention:   Drug: valsartan/amlodipine
Sponsor:   Novartis
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Drug Interaction Study of Avanafil and Enalapril or Amlodipine

Condition:   Erectile Dysfunction
Interventions:   Drug: avanafil and enalapril;   Drug: avanafil and amlodipine
Sponsor:   VIVUS, Inc.
Completed

Wed, 05 May 2010 12:00:00 EDT

A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)

Condition:   Hypertension
Interventions:   Drug: Comparator: amlodipine besylate;   Drug: Comparator: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Tue, 11 Nov 2008 12:00:00 EST

Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: Temisartan+Amlodipine+Rosuvastatin (Combination drug);   Drug: Temisartan+Amlodipine;   Drug: Temisartan+Rosuvastatin
Sponsor:   Yuhan Corporation
Completed

Wed, 01 Mar 2017 12:00:00 EST

Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)

Condition:   Hypertension
Interventions:   Drug: CKD-330 8/5mg;   Drug: Candesartan 8mg and Amlodipine 5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Thu, 10 Jul 2014 12:00:00 EDT

Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

Condition:   Essential Hypertension
Intervention:   Drug: Irbesartan/Amlodipine
Sponsor:   Handok Inc.
Recruiting

Tue, 28 Jul 2020 12:00:00 EDT

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Valsartan/amlodipine 160/5 mg;   Drug: Valsartan 160 mg;   Drug: Placebo
Sponsor:   Novartis
Completed

Mon, 26 Oct 2009 12:00:00 EDT

Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy

Condition:   Hypertension
Interventions:   Drug: irbesartan/amlodipine;   Drug: irbesartan
Sponsor:   Sanofi
Completed

Wed, 12 Aug 2009 12:00:00 EDT

Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: Temisartan/Amlodipine+Rosuvastatin;   Drug: YHP1604
Sponsor:   Yuhan Corporation
Completed

Mon, 17 Apr 2017 12:00:00 EDT

Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin

Condition:   Healthy Volunteers
Intervention:   Drug: Ramipril, Amlodipine and Atorvastatin
Sponsor:   Midas Pharma GmbH
Completed

Mon, 10 Feb 2020 12:00:00 EST

A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

Condition:   HYPERTENSION
Intervention:   Drug: valsartan + amlodipine
Sponsor:   Novartis
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

Condition:   Hypertension
Intervention:   Drug: valsartan/amlodipine
Sponsor:   Novartis
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety

Conditions:   Hypertension;   Anxiety
Interventions:   Drug: Tandospirone + Amlodipine;   Drug: Tandospirone placebo + Amlodipine;   Drug: Tandospirone + Amlodipine placebo;   Drug: Tandospirone placebo + Amlodipine placebo
Sponsor:   Chongqing Medical University
Unknown status

Wed, 12 Sep 2018 12:00:00 EDT

Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes

Conditions:   Hypertension;   Obesity;   Diabetes
Interventions:   Drug: Temisartan;   Drug: Amlodipine
Sponsor:   Third Military Medical University
Completed

Thu, 19 Feb 2009 12:00:00 EST

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine plus Losartan;   Drug: Amlodipine;   Drug: Losartan
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Mon, 20 Jul 2009 12:00:00 EDT

Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine

Condition:   Essential Hypertension
Interventions:   Drug: telmisartan plus hydrochlorothiazide;   Device: Amlodipine
Sponsor:   Tokyo University
Completed

Tue, 31 Jul 2007 12:00:00 EDT

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: Telmisartan/S-Amlodipine;   Drug: Rosuvastatin;   Drug: Telmisartan/S-Amlodipine + Rosuvastatin
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Tue, 28 Jan 2014 12:00:00 EST

A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Aliskiren;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
Sponsor:   Novartis
Completed

Mon, 28 Apr 2008 12:00:00 EDT

Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

Condition:   Hypertension
Interventions:   Drug: amlodipine/valsartan;   Drug: hydrochlorothiazide/telmisartan
Sponsor:   Yonsei University
Completed

Wed, 27 Mar 2013 12:00:00 EDT

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Condition:   Hypertension, Hyperlipidemia
Intervention:   Drug: Fimasartan/Amlodipine combination drug, Rosuvastatin
Sponsor:   Boryung Pharmaceutical Co., Ltd
Completed

Fri, 16 Dec 2016 12:00:00 EST

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

Conditions:   Lower Leg Edema;   Orthostatic Hypertension
Interventions:   Drug: Levacalm;   Drug: Valsartan/amlodipine
Sponsor:   LG Life Sciences
Unknown status

Tue, 14 Apr 2015 12:00:00 EDT

DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: AM 5 + DM 0;   Drug: AM 5 + DM 2.5;   Drug: AM 5 + DM 7.5;   Drug: AM 5 + DM 30
Sponsor:   TSH Biopharm Corporation Limited
Completed

Thu, 07 Jun 2012 12:00:00 EDT

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.

Condition:   Hypertension
Intervention:   Drug: valsartan+amlodipine combination, valsartan, amlodipine
Sponsor:   Novartis
Completed

Mon, 11 Dec 2006 12:00:00 EST

The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

Condition:   Healthy Male Volunteer
Interventions:   Drug: Telmisartan;   Drug: Amlodipine;   Drug: Rosuvastatin
Sponsor:   Yuhan Corporation
Completed

Mon, 08 Sep 2014 12:00:00 EDT

To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets

Condition:   Hypertension
Interventions:   Drug: Fimasartan;   Drug: Amlodipine;   Drug: Fimasartan/Amlodipine combination
Sponsors:   Boryung Pharmaceutical Co., Ltd;   Kyunghee university hospital A Drug Analytical Laboratory
Completed

Thu, 31 Jul 2014 12:00:00 EDT

Once-daily Fixed Combination of Three Antihypertensive Drugs

Condition:   Arterial Hypertension
Interventions:   Drug: perindopril, indapamide , amlodipine;   Drug: Tripliam (perindopril, indapamide, amlodipine)
Sponsor:   University of Roma La Sapienza
Unknown status

Wed, 16 Mar 2016 12:00:00 EDT

Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

Condition:   Healthy
Intervention:   Drug: CJ Amlodipine/Valsartan 10/160mg Novartis Exforge 10/160mg
Sponsor:   HK inno.N Corporation
Completed

Wed, 28 Nov 2012 12:00:00 EST

A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers

Conditions:   Hepatitis C;   Hypertension
Interventions:   Drug: Amlodipine;   Drug: Diltiazem
Sponsors:   Ottawa Hospital Research Institute;   Merck Sharp & Dohme Corp.
Withdrawn

Fri, 09 Mar 2012 12:00:00 EST

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

Condition:   Healthy
Interventions:   Drug: Amlodipine 5mg capsule;   Drug: T80/H12.5 mg FDC tablet;   Drug: T80/A5/H12.5 mg FDC tablet
Sponsor:   Boehringer Ingelheim
Completed

Fri, 02 May 2014 12:00:00 EDT

A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study

Condition:   Hypertension
Interventions:   Drug: GSK2944404 FDC;   Drug: Amlodipine 5 mg;   Drug: Enalapril Maleate 20 mg
Sponsor:   GlaxoSmithKline
Completed

Tue, 02 Apr 2013 12:00:00 EDT

Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

Condition:   Hypertension; Hypertrophy, Left Ventricular
Interventions:   Drug: Valsartan;   Drug: Amlodipine;   Drug: Hydrochlorothiazide;   Drug: Losartan
Sponsor:   Novartis
Completed

Tue, 13 Mar 2007 12:00:00 EDT

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers

Condition:   Hypertension
Interventions:   Drug: Reference Treatment: 1 x 5mg amlodipine tablet and 1 x 100mg losartan tablet administered in fasted state;   Drug: Fixed Dose Combination 1: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state;   Drug: Fixed Dose Combination 2: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state
Sponsor:   GlaxoSmithKline
Completed

Tue, 24 Jul 2012 12:00:00 EDT

Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension

Condition:   Essential Hypertension
Intervention:   Drug: multiple dose, crossover study between single and concomitant administrations of amlodipine, losartan, and hydrochlorothiazide
Sponsor:   Yonsei University
Completed

Fri, 10 Sep 2010 12:00:00 EDT

A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers

Condition:   Essential Hypertension
Interventions:   Drug: Fimasartan;   Drug: Amlodipine
Sponsor:   Boryung Pharmaceutical Co., Ltd
Completed

Mon, 13 Jul 2009 12:00:00 EDT

Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

Condition:   Hypertension
Intervention:   Drug: Telminuvo®Tab. 40/2.5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Unknown status

Tue, 18 Aug 2015 12:00:00 EDT

Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

Condition:   Healthy
Interventions:   Drug: DWJ1351(FDC Amlodipine/Olmesartan/Rosuvastatin);   Drug: Sevikar and Crestor
Sponsor:   Daewoong Pharmaceutical Co. LTD.
Completed

Tue, 27 Nov 2018 12:00:00 EST

Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan/Amlodipine FDC;   Drug: Telmisartan;   Drug: Amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Thu, 17 Jul 2014 12:00:00 EDT

Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan/Amlodipine;   Other: high fat, high caloric meal
Sponsor:   Boehringer Ingelheim
Completed

Thu, 09 Oct 2014 12:00:00 EDT

Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan/amlodipine fixed-dose combination tablet;   Drug: Telmisartan;   Drug: Amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Thu, 09 Oct 2014 12:00:00 EDT

Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure

Condition:   Kidney Failure, Chronic
Interventions:   Drug: Amlodipine;   Drug: Placebo
Sponsor:   Charite University, Berlin, Germany
Completed

Fri, 29 Jul 2005 12:00:00 EDT

Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan/amlodipine fixed-dose combination (FDC) tablet;   Drug: Telmisartan;   Drug: Amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Thu, 09 Oct 2014 12:00:00 EDT

Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan/Amlodipine low dose;   Drug: Telmisartan/Amlodipine high dose;   Other: Japanese meal
Sponsor:   Boehringer Ingelheim
Completed

Fri, 10 Oct 2014 12:00:00 EDT

Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance

Conditions:   Hypertension;   Type 2 Diabetes Mellitus
Interventions:   Drug: Valsartan;   Drug: Amlodipine
Sponsor:   Nagoya University
Completed

Thu, 11 Aug 2005 12:00:00 EDT

Amlodipine Diabetic Hypertension Efficacy Response Trial

Condition:   Hypertension
Intervention:   Drug: Amlodipine
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Mon, 12 Sep 2005 12:00:00 EDT

Direct Renin Inhibition Effects on Atherosclerotic Biomarkers

Conditions:   Coronary Artery Disease;   Type 2 Diabetes Mellitus
Interventions:   Drug: Aliskiren;   Drug: Amlodipine
Sponsor:   Texas Tech University Health Sciences Center
Completed

Thu, 08 Jan 2009 12:00:00 EST

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subjects

Condition:   Hypertension
Interventions:   Drug: Fimasartan/Amlodipine;   Drug: Fimasartan + Amlodipine
Sponsor:   Boryung Pharmaceutical Co., Ltd
Completed

Fri, 30 Sep 2016 12:00:00 EDT

Diurnal Variation in Hypertensive Stroke Patients

Conditions:   Hypertension;   Stroke
Intervention:   Drug: Amlodipine, Losartan
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Fri, 12 Apr 2013 12:00:00 EDT

Effects of Amlodipine in the Management of Chronic Heart Failure

Condition:   Chronic Heart Failure
Intervention:   Drug: Amlodipine
Sponsor:   Rennes University Hospital
Terminated

Fri, 09 Sep 2005 12:00:00 EDT

A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.

Condition:   Hypertension
Intervention:   Drug: amlodipine/benazepril
Sponsors:   Novartis;   Pfizer
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

Conditions:   Type 2 Diabetes;   Hypertension
Intervention:   Drug: amlodipine, hydralazine, terazosin or hydrochlorothiazide
Sponsor:   Tulane University School of Medicine
Completed

Mon, 27 Jan 2014 12:00:00 EST

The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.

Condition:   Hypertension
Intervention:   Drug: Amlodipine and Hydrocholorothiazide
Sponsor:   University of New Mexico
Terminated

Fri, 11 Apr 2008 12:00:00 EDT

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

Conditions:   Essential Hypertension;   Hyperlipidemia
Interventions:   Drug: Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg;   Drug: atorvastatin 40mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Mon, 29 Apr 2013 12:00:00 EDT

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: valsartan+amlodipine combination;   Drug: valsartan;   Drug: amlodipine
Sponsor:   Novartis
Completed

Mon, 11 Dec 2006 12:00:00 EST

Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"

Condition:   Hypertension
Intervention:   Drug: Candesartan cilexetil/Amlodipine besilate
Sponsor:   Takeda
Completed

Fri, 21 Feb 2014 12:00:00 EST

Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: Valsartan
Sponsor:   Novartis Pharmaceuticals
Completed

Wed, 18 Jun 2008 12:00:00 EDT

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

Condition:   Hypertension
Intervention:   Drug: valsartan/amlodipine
Sponsor:   Novartis
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

Condition:   Hypertension With Hyperlipidemia
Interventions:   Drug: Telmisartan/Amlodipine;   Drug: Rosuvastatin;   Drug: Telmisartan
Sponsor:   IlDong Pharmaceutical Co Ltd
Completed

Mon, 25 Jun 2018 12:00:00 EDT

Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan/Amlodipine;   Drug: Telmisartan/Amlodipine/HCTZ;   Drug: Telmisartan/HCTZ
Sponsor:   Boehringer Ingelheim
Completed

Tue, 08 Jul 2014 12:00:00 EDT

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine 5 mg;   Drug: Valsartan 80 mg;   Drug: Valsartan 40 mg;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed

Tue, 17 Jun 2008 12:00:00 EDT

Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension

Condition:   Hypertension
Interventions:   Drug: Olmesartan medoxomil;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
Sponsor:   Daiichi Sankyo, Inc.
Completed

Tue, 01 Apr 2008 12:00:00 EDT

Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension

Condition:   Hypertension
Interventions:   Drug: Valsartan 320 mg;   Drug: Amlodipine 10 mg;   Drug: Hydrochlorothiazide
Sponsor:   Novartis
Completed

Thu, 15 Sep 2005 12:00:00 EDT

The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: Rosuvastatin;   Drug: Telmisartan/Amlodipine;   Drug: Rosuvastatin and Telmisartan/Amlodipine
Sponsor:   Jeil Pharmaceutical Co., Ltd.
Completed

Fri, 13 Mar 2015 12:00:00 EDT

A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

Condition:   Healthy
Interventions:   Drug: Telmisartan 80mg;   Drug: Amlodipine10mg;   Drug: Hydrochlorothiazide
Sponsor:   IlDong Pharmaceutical Co Ltd
Completed

Tue, 26 Mar 2019 12:00:00 EDT

Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine

Condition:   Hypertension
Interventions:   Drug: placebo;   Drug: telmisartan + HCTZ;   Drug: amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Tue, 30 Jul 2013 12:00:00 EDT

Filtered Trial for Amlodipine Non-responder

Condition:   Hypertension
Interventions:   Drug: telmisartan+amlodipine;   Drug: amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Wed, 14 Nov 2007 12:00:00 EST

Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

Condition:   Raynaud Phenomenon
Intervention:   Drug: Udenafil or Amlodipine
Sponsors:   Seoul National University Hospital;   Dong-A Pharmaceutical Co., Ltd.
Completed

Thu, 20 Jan 2011 12:00:00 EST

Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo;   Drug: Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo;   Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide;   Drug: olmesartan medoxomil + amlodipine
Sponsor:   Daiichi Sankyo, Inc.
Completed

Thu, 18 Jun 2009 12:00:00 EDT

Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet

Condition:   Healthy
Intervention:   Drug: Amlodipine
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Fri, 30 Oct 2009 12:00:00 EDT

Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation

Condition:   Atrial Fibrillation
Interventions:   Drug: Telmisartan 80 mg and amlodipine 5 mg;   Drug: Placebo (for telmisartan and amlodipine)
Sponsor:   Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Completed

Tue, 12 Apr 2016 12:00:00 EDT

Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: Telmisartan low;   Drug: Telmisartan high;   Drug: amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Fri, 18 Jul 2014 12:00:00 EDT

Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose

Condition:   We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.
Intervention:   Drug: Amlodipine
Sponsor:   Gulhane School of Medicine
Completed

Fri, 30 Nov 2012 12:00:00 EST

Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Olmesartan medoxomil 40 mg - Amlodipine 10 mg;   Drug: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg;   Drug: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg;   Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg;   Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 25mg
Sponsor:   Daiichi Sankyo, Inc.
Completed

Fri, 15 May 2009 12:00:00 EDT

Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

Condition:   Hypertension
Interventions:   Drug: telmisartan/amlodipine 40/5mg;   Drug: YH22162 40/5/12.5 mg;   Drug: telmisartan/amlodipine 80/5mg;   Drug: YH22162 80/5/25 mg;   Drug: telmisartan/amlodipine 40/5mg placebo;   Drug: YH22162 40/5/12.5 mg placebo;   Drug: telmisartan/amlodipine 80/5mg placebo;   Drug: YH22162 80/5/25 mg placebo
Sponsor:   Yuhan Corporation
Completed

Wed, 02 Dec 2015 12:00:00 EST

Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension

Condition:   Hypertension
Interventions:   Drug: Telmisartan;   Device: Amlodipine;   Drug: Placebo
Sponsor:   Boehringer Ingelheim
Completed

Fri, 27 Jun 2014 12:00:00 EDT

Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

Condition:   Healthy
Interventions:   Drug: CJ Amlodipine/Valsartan 10/160mg;   Drug: Novartis Exforge 10/160mg
Sponsor:   HK inno.N Corporation
Completed

Mon, 19 Dec 2011 12:00:00 EST

Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Condition:   Hypertension
Interventions:   Drug: valsartan;   Drug: amlodipine
Sponsor:   Novartis
Completed

Fri, 17 Mar 2006 12:00:00 EST

Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions

Condition:   Hypertension
Interventions:   Drug: Amlodipine+Rosuvastatin;   Drug: GSK3074477 FDC - 1;   Drug: GSK3074477 FDC - 2
Sponsors:   GlaxoSmithKline;   SingHealth Investigational Medicine Unit, Singapore
Completed

Mon, 03 Mar 2014 12:00:00 EST

Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Aliskiren/Amlodipine 150/2.5 mg;   Drug: Aliskiren/amlodipine 150/5 mg;   Drug: Aliskiren 150 mg;   Drug: Amlodipine 2.5 mg;   Drug: Placebo of Aliskiren;   Drug: Placebo of Amlodipine;   Drug: Placebo of Aliskiren/amlodipine 150/2.5 mg;   Drug: Placebo of Aliskiren/amlodipine 150/5 mg
Sponsor:   Novartis
Completed

Tue, 09 Nov 2010 12:00:00 EST

Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: Valsartan plus Hydrochlorothiazide (80mg/12.5mg);   Drug: Amlodipine (5mg)
Sponsor:   Novartis
Completed

Wed, 24 Jan 2007 12:00:00 EST

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg

Condition:   Hypertension
Interventions:   Drug: Valsartan/amlodipine 80/5 mg tablets;   Drug: Amlodipine 5 mg capsules;   Drug: Amlodipine 10 mg capsules;   Drug: Atenolol 50 mg tablets;   Drug: Atenolol 100 mg tablets
Sponsor:   Novartis Pharmaceuticals
Completed

Mon, 02 Jun 2008 12:00:00 EDT

A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: amlodipine 10 mg;   Drug: manidipine 20 mg;   Drug: amlodipine 5 mg + delapril 30 mg;   Drug: manidipine 10 mg + delapril 30 mg
Sponsors:   University of Erlangen-Nürnberg Medical School;   Chiesi Farmaceutici S.p.A.
Completed

Tue, 04 Mar 2008 12:00:00 EST

Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: LCZ696;   Drug: Amlodipine;   Drug: LCZ696 and amlodipine combination;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Withdrawn

Thu, 30 May 2013 12:00:00 EDT

Levamlodipine Maleate or Amlodipine Besylate for Treatment of Hypertension: A Comparative Effectiveness Research

Condition:   Primary Hypertension
Intervention:  
Sponsors:   Peking University First Hospital;   Ministry of Science and Technology of the People´s Republic of China;   Southern Medical University, China;   CSPC Ouyi Pharmaceutical Co., Ltd.
Unknown status

Wed, 01 May 2013 12:00:00 EDT

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

Condition:   Hypertension
Intervention:   Drug: Amlodipine + Olmesartan medoxomil
Sponsor:   Pfizer
Terminated

Mon, 13 Sep 2010 12:00:00 EDT

Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus

Condition:   Albuminuria
Intervention:   Drug: amlodipine/benazepril
Sponsor:   Novartis
Completed

Mon, 29 Aug 2005 12:00:00 EDT

Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension

Condition:   Hypertension
Interventions:   Drug: fixed dose combination of telmisartan+amlodipine;   Drug: amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Sun, 04 Nov 2007 12:00:00 EDT

Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension

Conditions:   Hypertension;   Left Ventricular Hypertrophy
Intervention:   Drug: amlodipine/benazepril
Sponsor:   Novartis
Completed

Wed, 31 Aug 2005 12:00:00 EDT

Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension

Condition:   Hypertension
Interventions:   Drug: fixed dose combination of telmisartan+amlodipine;   Drug: amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Thu, 15 Nov 2007 12:00:00 EST

Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine

Condition:   Hypertension
Intervention:   Drug: SK3530 100mg, Placebo, Amlodipine
Sponsor:   SK Chemicals Co., Ltd.
Completed

Fri, 29 Feb 2008 12:00:00 EST

Irbesartan and Amlodipine Combination in Controlling Blood Pressure

Condition:   Hypertension
Interventions:   Drug: IRBESARTAN (SR47436);   Drug: Amlodipine;   Drug: Irbesartan / Amlodipine;   Drug: Placebo
Sponsor:   Sanofi
Completed

Fri, 31 Jul 2009 12:00:00 EDT

BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions

Condition:   Healthy Subjects
Interventions:   Drug: Torrent's Olmesartaan medoxomil, Amlodipine and Hydrochlorothiazide Tablets;   Drug: Tribenzor of Daichi Sankyo Inc. USA
Sponsor:   Torrent Pharmaceuticals Limited
Completed

Fri, 11 Nov 2016 12:00:00 EST

Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: Placebo;   Drug: Aliskiren 150 mg tablet;   Drug: Aliskiren 300 mg tablet;   Drug: Amlodipine 5 mg capsule;   Drug: Amlodipine 10 mg capsule;   Drug: Aliskiren/amlodipine 150/5 mg tablet;   Drug: Aliskiren/amlodipine 150/10 mg tablet;   Drug: Aliskiren/amlodipine 300/5 mg tablet;   Drug: Aliskiren/amlodipine 300/10 mg tablet
Sponsor:   Novartis Pharmaceuticals
Completed

Fri, 22 Aug 2008 12:00:00 EDT

Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy

Condition:   Hypertension
Interventions:   Drug: Irbesartan/Amlodipine (150/5mg);   Drug: Irbesartan/Amlodipine (150/10mg);   Drug: Irbesartan/Amlodipine (300/5mg);   Drug: Irbesartan/Amlodipine (300/10mg)
Sponsor:   Sanofi
Completed

Thu, 21 Jun 2012 12:00:00 EDT

Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

Condition:   Healhty
Interventions:   Drug: Amlodipine and Benazepril HCl Capsules 10 mg/20 mg;   Drug: Lotrel® Capsules 10 mg/20 mg
Sponsor:   Mylan Pharmaceuticals
Completed

Tue, 01 Apr 2008 12:00:00 EDT

Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

Condition:   Healthy
Interventions:   Drug: Amlodipine and Benazepril HCl Capsules 10 mg/20 mg;   Drug: Lotrel® Capsules 10 mg/20 mg
Sponsor:   Mylan Pharmaceuticals
Completed

Tue, 01 Apr 2008 12:00:00 EDT

Amlodipine Plus Botulinum Toxin for Focal Dystonia

Condition:   Focal Dystonia
Intervention:   Drug: Amlodipine plus Botulinum toxin
Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
Completed

Thu, 19 Apr 2001 12:00:00 EDT

An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

Condition:   Hypertension
Interventions:   Drug: telmisartan40/amlodipine5;   Drug: telmisartan80/amlodipine5
Sponsor:   Boehringer Ingelheim
Completed

Wed, 20 Feb 2008 12:00:00 EST

CKD-828 Drug Interaction Study (Telmisartan)

Condition:   Healthy Male Volunteers
Interventions:   Drug: Telmisartan 80mg, S-amlodipine 5mg;   Drug: Telmisartan 80mg
Sponsors:   Chong Kun Dang Pharmaceutical;   Asan Medical Center
Completed

Thu, 19 May 2011 12:00:00 EDT

Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)

Condition:   Hypertension
Interventions:   Drug: 40 mg telmisartan;   Drug: 5 mg amlodipine;   Drug: 80 mg telmisartan
Sponsor:   Boehringer Ingelheim
Completed

Mon, 31 Jan 2011 12:00:00 EST

Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects

Condition:   Healthy Subjects
Interventions:   Drug: Amlodipine 10 mg;   Drug: Levamlodipine 5 mg
Sponsor:   The Affiliated Hospital of Qingdao University
Completed

Tue, 02 Jun 2020 12:00:00 EDT

The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy

Condition:   Hypertension
Interventions:   Drug: Telminuvo®Tab. 40/2.5mg;   Drug: Telmitrend®Tab. 80mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Thu, 04 Sep 2014 12:00:00 EDT

A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

Condition:   Hypertension
Intervention:   Drug: valsartan + amlodipine
Sponsor:   Novartis
Completed

Wed, 25 Oct 2006 12:00:00 EDT

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

Condition:   Hypertension
Interventions:   Drug: Candesartan 8mg;   Drug: Amlodipine 5mg;   Drug: CKD-330 8/5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Mon, 14 Sep 2015 12:00:00 EDT

Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects

Condition:   Hypertension
Interventions:   Drug: Fimasartan;   Drug: Amlodipine;   Drug: Rosuvastatin
Sponsors:   Boryung Pharmaceutical Co., Ltd;   Inje University
Completed

Wed, 25 Mar 2015 12:00:00 EDT

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

Condition:   Hypertension
Intervention:   Drug: valsartan + amlodipine
Sponsor:   Novartis
Completed

Mon, 10 Jul 2006 12:00:00 EDT

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

Condition:   Hypertension
Intervention:   Drug: valsartan + amlodipine
Sponsor:   Novartis
Completed

Wed, 19 Jul 2006 12:00:00 EDT

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: Olmesartan medoxomil plus amlodipine
Sponsor:   Daiichi Sankyo, Inc.
Completed

Tue, 11 Sep 2007 12:00:00 EDT

The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes

Conditions:   Type 1 Diabetes;   Diabetic Retinopathy;   Eye Diseases;   Diabetes Complications
Interventions:   Drug: Amlodipine;   Drug: Lisinopril
Sponsors:   University of Aarhus;   Velux Fonden
Completed

Thu, 15 Jun 2006 12:00:00 EDT

Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

Condition:   Hypertension
Intervention:   Drug: valsartan + amlodipine
Sponsor:   Novartis
Completed

Thu, 24 Aug 2006 12:00:00 EDT

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

Conditions:   Hypertension;   Hyperlipidemia
Intervention:   Drug: Amlodipine/atorvastatin single pill
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Fri, 02 Sep 2005 12:00:00 EDT

Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia

Conditions:   Hypertension;   Dyslipidemia
Intervention:   Drug: Amlodipine/Atorvastatin
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Mon, 29 May 2006 12:00:00 EDT

Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients

Conditions:   Diabetes Mellitus;   Hypertension
Interventions:   Drug: Fimasartan;   Drug: Amlodipine
Sponsor:   Seoul National University Hospital
Completed

Tue, 09 Dec 2014 12:00:00 EST

Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension

Condition:   Hypertension
Intervention:   Drug: Valsartan, hydrochlorothiazide and amlodipine
Sponsor:   Novartis
Completed

Fri, 17 Nov 2006 12:00:00 EST

Telmisartan, Amlodipine and Flow Mediated Dilation

Condition:   Hypertension
Interventions:   Drug: Telmisartan;   Drug: Amlodipine;   Drug: Olmesartan medoxomil;   Drug: Hydrochlorothiazide
Sponsor:   Johannes Gutenberg University Mainz
Unknown status

Thu, 12 Aug 2010 12:00:00 EDT

Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Valsartan + amlodipine 40/2.5 mg;   Drug: Valsartan + amlodipine 40/5 mg;   Drug: Valsartan + amlodipine 80/2.5 mg;   Drug: Valsartan + amlodipine 80/5 mg;   Drug: Valsartan 40 mg;   Drug: Valsartan 80 mg;   Drug: Amlodipine 2.5 mg;   Drug: Amlodipine 5 mg;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed

Tue, 23 Jan 2007 12:00:00 EST

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Condition:   Hypertension
Interventions:   Drug: valsartan;   Drug: amlodipine
Sponsor:   Novartis
Completed

Wed, 12 Jul 2006 12:00:00 EDT

The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients

Conditions:   Uncomplicated Hypertension;   Hypertension;   Essential
Interventions:   Drug: Lacidipine 4 or 6 mg (oral);   Drug: Amlodipine 5 or 10 mg(oral)
Sponsor:   GlaxoSmithKline
Completed

Tue, 20 Jun 2006 12:00:00 EDT

Open Label Study Telmisartan and Amlodipine in Hypertension

Condition:   Hypertension
Interventions:   Drug: telmisartan/amlodipine 40/5 mg fixed combination;   Drug: telmisartan/amlodipine 80/5 mg fixed combination
Sponsor:   Boehringer Ingelheim
Completed

Wed, 13 Feb 2008 12:00:00 EST

Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 Years

Condition:   Hypertension
Intervention:   Drug: Lacidipine & Amlodipine
Sponsors:   Korea University Guro Hospital;   GlaxoSmithKline
Completed

Tue, 17 Apr 2007 12:00:00 EDT

Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

Condition:   Hypertension
Interventions:   Drug: Valsartan/HCTZ;   Drug: amlodipine;   Drug: HCTZ
Sponsor:   Novartis
Completed

Wed, 24 Jan 2007 12:00:00 EST

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

Conditions:   Hypertension;   Stage 2 Hypertension;   Diabetes
Interventions:   Drug: Valturna;   Drug: Amlodipine;   Drug: Chlorthalidone;   Drug: Placebo of Valturna Tablet;   Drug: Placebo Capsule
Sponsor:   Novartis Pharmaceuticals
Terminated

Wed, 08 Jun 2011 12:00:00 EDT

Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

Condition:   Cerebral Small Vessel Diseases
Interventions:   Drug: Amlodipine;   Drug: Losartan;   Drug: Atenolol
Sponsors:   Ludwig-Maximilians - University of Munich;   University of Edinburgh;   Maastricht University Medical Center;   UMC Utrecht;   University of Oxford
Recruiting

Fri, 17 Mar 2017 12:00:00 EDT

26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension

Condition:   Hypertension
Interventions:   Drug: fixed-dose combination of telmisartan 40mg+amlodipine 10mg;   Drug: fixed-dose combination of telmisartan 80mg+amlodipine10mg
Sponsor:   Boehringer Ingelheim
Completed

Tue, 26 Feb 2008 12:00:00 EST

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.

Conditions:   Hypertension;   Hyperlipidemia
Intervention:   Drug: Amlodipine/atorvastatin single pill
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)

Condition:   Hypertension
Interventions:   Drug: Telmisartan;   Drug: Amlodipine;   Drug: Chlorthalidone
Sponsor:   Yuhan Corporation
Completed

Mon, 02 Jun 2014 12:00:00 EDT

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

Condition:   Essential Hypertension
Intervention:   Drug: olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary
Sponsor:   Sankyo Pharma Gmbh
Completed

Wed, 05 Apr 2006 12:00:00 EDT

Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic

Condition:   Hypertension
Intervention:   Drug: Amlodipine
Sponsors:   Queen Mary University of London;   Closed Loop Medicine Ltd;   Innovate UK
Recruiting

Tue, 22 Sep 2020 12:00:00 EDT

BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF

Conditions:   Heart Failure With Preserved Ejection Fraction;   Hypertension
Interventions:   Drug: Amlodipine Besylate;   Drug: Metoprolol Succinate
Sponsors:   University of Pennsylvania;   Julio Chirinos, MD, PhD;   Raymond Townsend, MD
Recruiting

Wed, 17 Jun 2020 12:00:00 EDT

Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: Valsartan/hydrochlorothiazide (HCTZ);   Drug: Valsartan/amlodipine;   Drug: Amlodipine/hydrochlorothiazide(HCTZ);   Drug: Valsartan/amlodipine/hydrochlorothiazide(HCTZ)
Sponsor:   Novartis
Completed

Tue, 23 Oct 2007 12:00:00 EDT

A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia

Conditions:   Hypertension;   Hyperlipidemias
Interventions:   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg;   Drug: Olmesartan 40 mg, Rosuvastatin 20mg;   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug)
Sponsor:   Daewoong Pharmaceutical Co. LTD.
Unknown status

Wed, 04 Jan 2017 12:00:00 EST

Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)

Conditions:   Hypertension;   Coronary Atherosclerosis
Intervention:   Drug: Calcium channel blockers (amlodipine, azelnidipine)
Sponsors:   Juntendo University;   Japan Heart Foundation
Completed

Wed, 22 Feb 2006 12:00:00 EST

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

Conditions:   Adherence to Medication Regime;   Hypertensive Disease
Intervention:   Drug: Perindopril/Indapamide/Amlodipine fixed dose combination
Sponsor:   Servier Hellas Pharmaceuticals Ltd.
Completed

Wed, 13 Jan 2016 12:00:00 EST

Double Blind Atorvastatin Amlodipine Study

Condition:   Angina
Interventions:   Drug: amlodipine;   Drug: atorvastatin
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Mon, 12 Sep 2005 12:00:00 EDT

Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

Condition:   Dyslipidemia With Hypertension
Interventions:   Drug: Group I (Telmisartan 80 mg, Amlodipine 10 mg, Rosuvastatin 20 mg);   Drug: Group II (Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin placebo);   Drug: Group III (Telmisartan 80 mg, Amlodipine placebo, Rosuvastatin 20 mg)
Sponsor:   Jeil Pharmaceutical Co., Ltd.
Completed

Thu, 23 Mar 2017 12:00:00 EDT

The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

Conditions:   Hypertension;   Dyslipidemias
Interventions:   Drug: NEWSTATIN TS;   Drug: CADUET
Sponsor:   Hyo-Soo Kim
Unknown status

Fri, 01 Mar 2019 12:00:00 EST

CKD-828 (80/5mg) Pharmacokinetic Study

Condition:   Hypertension
Interventions:   Drug: CKD-828;   Drug: Telmisartan;   Drug: S-amlodipine
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Fri, 26 Sep 2014 12:00:00 EDT

MR Antagonist and LSD1

Conditions:   Hypertension;   Mineralocorticoid Excess
Interventions:   Drug: Eplerenone;   Drug: Amlodipine
Sponsor:   Brigham and Women's Hospital
Not yet recruiting

Mon, 12 Apr 2021 12:00:00 EDT

Telmisartan 80mg Non-responder Trial

Condition:   Hypertension
Interventions:   Drug: Telmisartan and amlodipine;   Drug: Telmisartan
Sponsor:   Boehringer Ingelheim
Completed

Mon, 18 Oct 2010 12:00:00 EDT

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: atorvastatin;   Drug: amlodipine
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg

Condition:   Hypertension
Interventions:   Drug: Candesartan cilexetil;   Drug: Olmesartan medoxomil;   Drug: Olmesartan/amlodipine
Sponsor:   Institut für Pharmakologie und Präventive Medizin
Completed

Mon, 04 Jun 2012 12:00:00 EDT

Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: telmisartan;   Drug: amlodipine
Sponsor:   First Affiliated Hospital Xi'an Jiaotong University
Recruiting

Tue, 21 May 2019 12:00:00 EDT

CKD-828 (80/5mg) Pharmacokinetic Study

Condition:   Hypertension
Interventions:   Drug: CKD-828;   Drug: Telmisartan;   Drug: S-amlodipine
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Mon, 09 Feb 2015 12:00:00 EST

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity

Condition:   Obesity-Associated Insulin Resistance
Interventions:   Drug: Moxonidine 0.2 MG;   Drug: Amlodipine 5 MG
Sponsors:   Italo Biaggioni;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting

Wed, 01 Apr 2020 12:00:00 EDT

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Condition:   Hypertension
Interventions:   Drug: subjects treated with telmisartan/hydrochlorothiazide;   Drug: Subjects treated with Telmisartan and amlodipine;   Drug: subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group;   Drug: subjects treated with telmisartan+amlodipine double pill
Sponsor:   Boehringer Ingelheim
Not yet recruiting

Sun, 02 Jul 2017 12:00:00 EDT

Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension

Condition:   Hypertension
Interventions:   Drug: Aliskiren;   Drug: Amlodipine;   Drug: Hydrochlorothiazide (HCTZ);   Drug: Placebo
Sponsor:   Novartis
Completed

Fri, 03 Oct 2008 12:00:00 EDT

Mechanism of Masked Hypertension - Intervention

Condition:   Masked Hypertension
Interventions:   Drug: Carvedilol;   Drug: Amlodipine
Sponsor:   University of Alabama at Birmingham
Not yet recruiting

Wed, 09 Oct 2019 12:00:00 EDT

Azilsartan Circadian and Sleep Pressure

Condition:   Hypertension
Interventions:   Drug: Azilsartan;   Drug: Amlodipine
Sponsors:   Sogo Rinsho Médéfi Co., Ltd.;   Takeda
Completed

Mon, 07 Jan 2013 12:00:00 EST

Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects

Condition:   Healthy
Intervention:   Drug: combination administration
Sponsor:   HK inno.N Corporation
Completed

Mon, 24 Feb 2014 12:00:00 EST

Amlodipine as add-on to Olmesartan in Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: olmesartan medoxomil;   Drug: amlodipine
Sponsor:   Sankyo Pharma Gmbh
Completed

Thu, 22 Sep 2005 12:00:00 EDT

An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy

Condition:   Hypertension
Interventions:   Drug: Telmisartan80mg+Amlodipine5mg;   Drug: amlodipine 5mg;   Drug: Telmisartan80mg+Amlodipine 5mg
Sponsor:   Boehringer Ingelheim
Completed

Thu, 15 Apr 2010 12:00:00 EDT

PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: YH22189;   Drug: Twynsta 80/10mg;   Drug: Crestor 20mg
Sponsor:   Yuhan Corporation
Terminated

Wed, 18 Nov 2015 12:00:00 EST

Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

Conditions:   Hypertension;   Hypercholesterolemia
Intervention:   Drug: Amlodipine besylate/atorvastatin calcium single pill combination
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Tue, 05 Dec 2006 12:00:00 EST

Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

Condition:   Hypertension
Interventions:   Drug: Olmesartan medoxomil;   Drug: Amlodipine
Sponsor:   Daiichi Sankyo, Inc.
Completed

Fri, 16 Sep 2005 12:00:00 EDT

Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep Apnea

Conditions:   Hypertension;   Sleep Apnea
Interventions:   Drug: Chlorthalidone plus amiloride;   Drug: Amlodipine
Sponsor:   Hospital de Clinicas de Porto Alegre
Completed

Mon, 12 Sep 2016 12:00:00 EDT

ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)

Condition:   Hypertension and Atrial Fibrillation
Interventions:   Drug: Telmisartan-amlodipine tablet administration group (morning);   Drug: Telmisartan-amlodipine tablet administration group (bedtime)
Sponsor:   Acrobat Trial Group
Unknown status

Wed, 12 Dec 2012 12:00:00 EST

MR Antagonist and STRIATIN

Conditions:   Hypertension;   Genetics Hypertension
Intervention:   Drug: Eplerenone vs Amlodipine
Sponsor:   Brigham and Women's Hospital
Recruiting

Tue, 25 Sep 2018 12:00:00 EDT

Add-on to Micamlo BP Trial

Condition:   Hypertension
Interventions:   Drug: Telmisartan + amlodipine;   Drug: hydrochlorothiazide;   Drug: Placebo
Sponsor:   Boehringer Ingelheim
Completed

Sun, 03 Nov 2013 12:00:00 EDT

A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients

Conditions:   Hypertension;   Obesity
Interventions:   Drug: Telmisartan plus Metformin;   Drug: Telmisartan;   Drug: Candesartan;   Drug: Candesartan plus Metformin;   Drug: Amlodipine;   Drug: Amlodipine plus Metformin
Sponsor:   Third Military Medical University
Completed

Tue, 02 Oct 2007 12:00:00 EDT

A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

Condition:   Hypertension
Interventions:   Drug: valsartan;   Drug: hydrochlorothiazide;   Drug: amlodipine
Sponsor:   Novartis
Completed

Thu, 18 May 2006 12:00:00 EDT

Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

Conditions:   Metabolic Syndrome;   Hypertension
Interventions:   Drug: Olmesartan medoxomil tablets low dose;   Drug: Olmesartan medoxomil tablets high dose;   Drug: Amlodipine
Sponsor:   Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Completed

Fri, 01 May 2009 12:00:00 EDT

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Condition:   Hypertension
Interventions:   Drug: Valsartan + amlodipine;   Drug: Valsartan + HCTZ;   Drug: Amlodipine + HCTZ;   Drug: Valsartan + amlodipine + HCTZ
Sponsor:   Novartis
Completed

Thu, 18 May 2006 12:00:00 EDT

High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: Quinapril 40 mg;   Drug: Quinapril 10 mg and amlodipine 5 mg
Sponsors:   Montreal Heart Institute;   Pfizer
Terminated

Wed, 12 Apr 2006 12:00:00 EDT

Efficacy and Safety of TELMINUVO to Stage 2 Hypertension

Condition:   Hypertension
Interventions:   Drug: TELMINUVO Tab. (80/2.5mg);   Drug: TELMINUVO Tab. (80/5mg);   Drug: S-amlodipine 2.5mg;   Drug: S-amlodipine 5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Unknown status

Thu, 14 Nov 2013 12:00:00 EST

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

Condition:   Essential Hypertension
Intervention:   Drug: olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary
Sponsor:   Daiichi Sankyo, Inc.
Completed

Thu, 30 Apr 2009 12:00:00 EDT

Cozaar XQ Re-examination Study (MK-0954-349)

Condition:   Hypertension
Intervention:   Drug: amlodipine/losartan
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Fri, 01 Jan 2010 12:00:00 EST

Management of Hypertension Utilizing Trained Community Health Worker in Rural Municipalities of Nepal

Condition:   Hypertension,Essential
Interventions:   Drug: Amlodipine;   Behavioral: Lifestyle counselling
Sponsors:   Johns Hopkins Bloomberg School of Public Health;   Nepal Development Society
Recruiting

Thu, 20 Aug 2020 12:00:00 EDT

Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: Amlodipine 10mg+Valsartan 160mg+Atorvastatin 40mg;   Drug: Amlodipine 10mg+Valsartan 160mg;   Drug: Valsartan 160mg+Atorvastatin 40mg
Sponsor:   HK inno.N Corporation
Unknown status

Tue, 21 Aug 2018 12:00:00 EDT

Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: losartan/hydrochlorothiazide;   Drug: amlodipine/hydrochlorothiazide
Sponsor:   Shanghai Jiao Tong University School of Medicine
Recruiting

Fri, 10 May 2019 12:00:00 EDT

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: Fimasartan/Amlodipine/Rosuvastatin;   Drug: Fimasartan/Amlodipine;   Drug: Rosuvastatin
Sponsor:   Boryung Pharmaceutical Co., Ltd
Completed

Wed, 07 Oct 2015 12:00:00 EDT

Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension

Conditions:   Lower Urinary Tract Symptoms;   Hypertension
Interventions:   Drug: amlodipine;   Drug: terazosin;   Drug: amlodipine plus terazosin
Sponsors:   Anhui Medical University;   The University of Science and Technology of China;   Peking University First Hospital
Completed

Fri, 06 Jun 2008 12:00:00 EDT

Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension

Condition:   Hypertension
Interventions:   Drug: Amlodipine 5 mg;   Drug: Placebo;   Drug: Telmisartan 20 mg;   Drug: Telmisartan 40 mg;   Drug: Amlodipine 10 mg;   Drug: Telmisartan 80 mg;   Drug: Amlodipine 2.5 mg
Sponsor:   Boehringer Ingelheim
Completed

Wed, 25 Jan 2006 12:00:00 EST

Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism

Condition:   Metabolic Syndrome
Interventions:   Other: Low Salt diet plus Placebo tablet;   Other: Low Sodium diet plus Salt tablet;   Drug: Epleronone;   Drug: Amlodipine
Sponsor:   Vanderbilt University Medical Center
Completed

Mon, 13 Jan 2014 12:00:00 EST

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)

Condition:   Healthy Male Subjects
Interventions:   Drug: Exforge tab. 10/160mg;   Drug: Lodivixx tab. 5/160mg
Sponsor:   Hanlim Pharm. Co., Ltd.
Completed

Mon, 27 Aug 2018 12:00:00 EDT

A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

Conditions:   Hypertension;   Hypercholesterolemia
Interventions:   Drug: Amlodipine 2.5mg/Atorvastatin 5mg;   Drug: Amlodipine 2.5mg/Atorvastatin 10mg;   Drug: Amlodipine 5mg/Atorvastatin 5mg;   Drug: Amlodipine 5mg/Atorvastatin 10mg
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Tue, 18 Sep 2007 12:00:00 EDT

Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina

Condition:   Myocardial Ischemia
Interventions:   Drug: Amlodipine;   Drug: iso- 5 - mononitrate;   Procedure: Blood tests;   Procedure: Exercise Stress Test
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Fri, 02 Sep 2005 12:00:00 EDT

Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: Telmisartan;   Drug: amlodipine
Sponsor:   Boehringer Ingelheim
Completed

Wed, 16 Mar 2011 12:00:00 EDT

The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension

Conditions:   Diabetes;   Hypertension;   Proteinuria
Interventions:   Drug: Amlodipine;   Drug: Valsartan
Sponsor:   Gulhane School of Medicine
Completed

Tue, 16 Jun 2009 12:00:00 EDT

Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab (Olmesartan 20 mg/Amlodipine 5 mg/Rosuvastatin 5 or 10 mg) in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease

Conditions:   Hypertension;   Dyslipidemias
Interventions:   Drug: OLOMAX 20/5/5mg;   Drug: OLOMAX 20/5/10mg;   Drug: Olmesartan 20 mg/Amlodipine 5 mg
Sponsor:   Daewoong Pharmaceutical Co. LTD.
Unknown status

Wed, 09 Oct 2019 12:00:00 EDT

Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

Condition:   Nonalcoholic Fatty Liver Disease (NAFLD)
Interventions:   Drug: Perindopril;   Drug: Telmisartan;   Drug: Amlodipine
Sponsor:   Nanfang Hospital of Southern Medical University
Unknown status

Mon, 11 Aug 2014 12:00:00 EDT

Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities

Conditions:   Hypertension;   Metabolic Syndrome X
Interventions:   Drug: Micardis;   Drug: Amlodipine;   Procedure: Abdominal biopsy
Sponsor:   Boehringer Ingelheim
Completed

Fri, 21 Oct 2005 12:00:00 EDT

An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

Condition:   Proteinuria
Interventions:   Drug: Losartan Potassium;   Other: Comparator: Placebo (Losartan);   Drug: Comparator: amlodipine besylate;   Other: Comparator: Placebo (amlodipine besylate);   Other: Placebo (Losartan);   Drug: Enalapril Maleate
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Wed, 05 Dec 2007 12:00:00 EST

N-of-1 Trials for Blood Pressure Medications in Adults

Conditions:   Hypertension;   High Blood Pressure
Interventions:   Drug: Losartan;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
Sponsor:   Columbia University
Completed

Wed, 20 Apr 2016 12:00:00 EDT

Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

Condition:   Essential Hypertension
Intervention:   Drug: Ali/Amlo 150/2.5 mg
Sponsor:   Novartis Pharmaceuticals
Completed

Wed, 10 Nov 2010 12:00:00 EST

A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: Twynsta 80/5mg;   Drug: Crestor 20mg
Sponsor:   Yuhan Corporation
Completed

Tue, 01 Nov 2016 12:00:00 EDT

Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

Condition:   Hypertension
Interventions:   Drug: MK0954, losartan potassium/Duration of Treatment: 18 weeks;   Drug: Comparator: losartan, HCTZ, amlodipine, atenolol/Duration of Treatment: 18 weeks
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Thu, 01 Sep 2005 12:00:00 EDT

Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

Condition:   Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
Interventions:   Drug: Olmesartan;   Drug: Amlodipine
Sponsor:   Kurume University
Unknown status

Mon, 19 Dec 2016 12:00:00 EST

A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)

Condition:   Hypertension
Interventions:   Drug: Telmisartan 80 mg + hydrochlorothiazide 12.5 mg;   Drug: Amlodipine 10 mg + hydrochlorothiazide 12.5 mg
Sponsor:   Boehringer Ingelheim
Completed

Tue, 18 Oct 2005 12:00:00 EDT

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk

Conditions:   Dyslipidemia;   Hypertension
Interventions:   Drug: Amlodipine besylate;   Drug: Amlodipine besylate/atorvastatin calcium single pill combination
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Fri, 15 Dec 2006 12:00:00 EST

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy

Conditions:   Diabetes Mellitus, Type 2;   Blood Pressure
Interventions:   Drug: Allisartan Isoproxil;   Drug: Amlodipine
Sponsor:   Guangdong Provincial People's Hospital
Not yet recruiting

Tue, 27 Jul 2021 12:00:00 EDT

Effect of Atorvastatin on Carotid Intima Media Thickness

Conditions:   Essential Hypertension;   Hypercholesterolemia
Intervention:   Drug: Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment
Sponsors:   Yerevan State Medical University;   Servier
Not yet recruiting

Fri, 13 Mar 2020 12:00:00 EDT

Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension

Condition:   Hypertension
Interventions:   Drug: Candesartan+HCTZ - Phase 1;   Drug: Aliskiren+HCTZ - Phase 2;   Drug: Aliskiren+HCTZ+amlodipine - Phase 3
Sponsor:   Novartis
Completed

Mon, 23 Mar 2009 12:00:00 EDT

DP-R212 Pharmacokinetic Study

Conditions:   Hypertension;   Hyperlipidemias
Interventions:   Drug: Amlodipine;   Drug: Rosuvastatin
Sponsor:   Alvogen Korea
Unknown status

Fri, 03 Jun 2016 12:00:00 EDT

Efficacy and Safety of CKD-828 to Stage 2 Hypertension

Condition:   Hypertension
Interventions:   Drug: CKD-828 2.5/40mg;   Drug: CKD-828 5/40mg;   Drug: CKD-828 5/80mg;   Drug: S-amlodipine 2.5mg;   Drug: S-amlodipine 5mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Fri, 06 Jul 2012 12:00:00 EDT

Fixed Combination for Lipid and Blood Pressure Control

Conditions:   Arterial Hypertension;   Dyslipidemias;   Blood Pressure;   Lipid Metabolism Disorders
Intervention:   Drug: Atorvastatin, Amlodipine, Perindopril
Sponsors:   Charles University, Czech Republic;   University Hospital Olomouc;   University Hospital Pilsen;   General Teaching Hospital, Prague;   St. Anne;   Brno University Hospital;   Na Homolce Hospital
Withdrawn

Thu, 09 Feb 2017 12:00:00 EST

Hypertension Control Based on Home Blood Pressure

Condition:   Hypertension
Intervention:   Drug: Amlodipine, Losartan
Sponsors:   Ministry of Health, Labour and Welfare, Japan;   Japan Cardiovascular Research Foundation
Unknown status

Tue, 20 Sep 2005 12:00:00 EDT

Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

Condition:   Hypertension
Intervention:   Drug: Losartan/amlodipine or losartan/hydrochlorothiazide
Sponsor:   Yokohama City University Medical Center
Completed

Wed, 27 Jun 2007 12:00:00 EDT

The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension

Condition:   Hypertension
Interventions:   Drug: Eplerenone;   Drug: Amlodipine;   Procedure: Microneurography;   Procedure: Rhythmic handgrip exercise;   Procedure: Sustained hand grip;   Procedure: Forearm blood flow;   Procedure: Arm cycling exercise;   Procedure: Cold Pressor test
Sponsor:   University of Texas Southwestern Medical Center
Recruiting

Wed, 27 Nov 2013 12:00:00 EST

Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study

Condition:   Hypertension
Interventions:   Drug: Perindopril;   Drug: Perindopril/amlodipine;   Drug: Olmesartan/amlodipine
Sponsors:   Monash University;   Schering-Plough
Withdrawn

Thu, 18 Mar 2010 12:00:00 EDT

Olmesartan as an add-on to Amlodipine in Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: olmesartan medoxomil;   Drug: amlodipine;   Drug: hydrochlorothiazide
Sponsor:   Sankyo Pharma Gmbh
Completed

Thu, 22 Sep 2005 12:00:00 EDT

A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

Condition:   Hypertension
Intervention:   Drug: Twynsta tablet
Sponsor:   Boehringer Ingelheim
Completed

Thu, 18 Nov 2010 12:00:00 EST

Low-dose Combination of Three Antihypertensive Drugs

Condition:   Arterial Hypertension
Interventions:   Drug: Tripliam (perindopril, indapamide, amlodipine);   Drug: Reaptan (perindopril, amlodipine)
Sponsor:   University of Roma La Sapienza
Unknown status

Wed, 16 Mar 2016 12:00:00 EDT

Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: Chlorthalidone;   Drug: Losartan
Sponsors:   Anthony J Viera, MD, MPH;   North Carolina Translational and Clinical Sciences Institute
Completed

Wed, 23 Apr 2014 12:00:00 EDT

Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial

Condition:   Blood Pressure
Interventions:   Drug: amlodipine 5/10 mg per day plus valsartan 160 mg/day;   Drug: hydrochlorothiazide 6.25 mg/day plus bisoprolol 5/10 mg/day
Sponsors:   KU Leuven;   University of Kinshasa;   Yaounde Central Hospital;   University of Yaounde;   University of Libreville;   Institute of Cardiology Abidjan;   University of Ilorin Teaching Hospital;   University of Nigeria, Enugu Campus;   Hospital Aristide Le Dantec, Dakar, Senegal
Completed

Fri, 11 Dec 2009 12:00:00 EST

Study of DWJ1351 in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: DWJ1351;   Drug: Co-administration of Sevikar (Olmesartan/Amlodipine) and Crestor (Rosuvastatin)
Sponsor:   Daewoong Pharmaceutical Co. LTD.
Unknown status

Thu, 28 Jan 2016 12:00:00 EST

MK-0954E Study in Participants With Hypertension (MK-0954E-357)

Condition:   Hypertension
Interventions:   Drug: losartan potassium + hydrochlorothiazide + amlodipine besylate (MK-0954E);   Drug: Losartan potassium;   Drug: Amlodipine besylate;   Drug: Placebo to MK-0954E;   Drug: Placebo to losartan potassium;   Drug: Placebo to amlodipine besylate
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Thu, 24 Feb 2011 12:00:00 EST

Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

Condition:   Hypertension With Hyperlipidemia
Interventions:   Drug: Amlodipine 10 mg + Valsartan 160 mg + Rosuvastatin 20 mg;   Drug: Amlodipine 10 mg + Valsartan 160 mg;   Drug: Valsartan 160 mg + Rosuvastatin 20 mg
Sponsor:   HK inno.N Corporation
Completed

Thu, 24 May 2018 12:00:00 EDT

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension

Condition:   Hypertension
Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo
Sponsor:   George Medicines PTY Limited
Recruiting

Wed, 19 Aug 2020 12:00:00 EDT

Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine

Condition:   Hypertension
Interventions:   Drug: Amlessa®;   Drug: Co-Amlessa®
Sponsors:   KRKA;   Clinres Farmacija d.o.o.;   University Medical Centre Ljubljana
Completed

Tue, 13 Nov 2018 12:00:00 EST

Vascular Augmentation of Late-life Unremitted Depression (VALUeD)

Condition:   Depression
Interventions:   Drug: Amlodipine;   Drug: Placebo
Sponsors:   Gateshead Health NHS Foundation Trust;   Newcastle-upon-Tyne Hospitals NHS Trust;   National Institute for Health Research, United Kingdom
Unknown status

Mon, 19 Mar 2012 12:00:00 EDT

Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)

Condition:   Hypertension
Interventions:   Drug: MK-4618;   Drug: Placebo for MK-4618;   Drug: Metoprolol;   Drug: Amlodipine
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Tue, 19 Apr 2011 12:00:00 EDT

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension

Conditions:   Obesity;   Hypertension
Interventions:   Drug: Moxonidine 0.4 MG;   Drug: Amlodipine 5mg
Sponsors:   Royal Perth Hospital;   The University of Western Australia
Recruiting

Fri, 17 Jul 2020 12:00:00 EDT

Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions

Condition:   Fasting
Intervention:   Drug: Amlodipin, losartan, HCTZ
Sponsor:   Pharmaceutical Research Unit, Jordan
Completed

Thu, 25 Oct 2012 12:00:00 EDT

Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.

Condition:   Healthy Subjects
Interventions:   Drug: Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets;   Drug: Tribenzor Tablets of Daichi Sankyo Inc, USA
Sponsor:   Torrent Pharmaceuticals Limited
Completed

Fri, 11 Nov 2016 12:00:00 EST

A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components

Condition:   Primary Hypertension
Interventions:   Drug: Metoprolol XL 50mg + Amlodipine 5mg;   Drug: Metoprolol XL 25 mg + Amlodipine 2.5mg;   Drug: Metoprolol XL 50mg;   Drug: Metoprolol XL 25 mg;   Drug: Amlodipine 5mg
Sponsors:   AstraZeneca;   St. John's Research Institute
Completed

Thu, 08 Jan 2009 12:00:00 EST

Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension

Condition:   Hypertension
Interventions:   Drug: Benazepril/amlodipine 20/5 mg - Dose Level 1 from Day 1 to Month 1;   Drug: Benazepril/amlodipine 40/5 mg - Dose Level 2 from Month 1 to Month 2;   Drug: Benazepril/amlodipine 40/10 mg - Dose Level 3 from Month 2 to Month 3 and thereafter;   Drug: Benazepril/hydrochlorothiazide 20/12.5 mg - Dose Level 1 from Day 1 to Month 1;   Drug: Benazepril/hydrochlorothiazide 40/12.5 mg - Dose Level 2 from Month 1 to Month 2;   Drug: Benazepril/hydrochlorothiazide 40/25 mg - Dose Level 3 from Month 2 to Month 3 and thereafter
Sponsor:   Novartis
Terminated

Thu, 15 Sep 2005 12:00:00 EDT

Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension

Condition:   Hypertension
Interventions:   Drug: Enalapril Folic Acid Tablets Combined With amlodipine;   Drug: Enalapril Folic Acid Tablets Combined With hydrochlorothiazide
Sponsors:   Second Affiliated Hospital, School of Medicine, Zhejiang University;   National Clinical Research Center, Southern Medical University;   Ningbo Yinzhou Community Health Service Center
Completed

Wed, 07 Jul 2021 12:00:00 EDT

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)

Condition:   Healthy Male Subjects
Interventions:   Drug: Exforge tab. 10/160mg;   Drug: Lodivixx tab. 5/160mg
Sponsor:   Hanlim Pharm. Co., Ltd.
Completed

Thu, 28 Mar 2013 12:00:00 EDT

Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients

Condition:   Essential Hypertension
Intervention:   Drug: Amlodipine, Telmisartan, Amiloride Compound , Simvastatin
Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital
Unknown status

Wed, 11 Nov 2009 12:00:00 EST

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects

Condition:   Healthy Male Subjects
Interventions:   Drug: Exforge tab. 10/160mg;   Drug: Lodivixx tab. 5/160mg
Sponsor:   Hanlim Pharm. Co., Ltd.
Completed

Mon, 30 Jul 2012 12:00:00 EDT

Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults

Condition:   Hypertension
Interventions:   Drug: HCTZ + Amlodipine;   Drug: Valsartan/HCTZ
Sponsor:   Novartis Pharmaceuticals
Completed

Mon, 26 Feb 2007 12:00:00 EST

Intermittent Hypoxia 2: Cardiovascular and Metabolism

Conditions:   Hypoxia;   Sleep Apnea;   Obstructive Sleep Apnea
Interventions:   Drug: Placebo;   Drug: Valsartan;   Drug: Amlodipine
Sponsors:   University Hospital, Grenoble;   Institut National de la Santé Et de la Recherche Médicale, France
Terminated

Mon, 10 Feb 2014 12:00:00 EST

Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus

Conditions:   Hypertension;   Kidney Transplantation
Interventions:   Drug: Chlorthalidone;   Drug: Amlodipine
Sponsor:   Erasmus Medical Center
Completed

Thu, 31 Dec 2015 12:00:00 EST

Aliskiren Study of Safety and Efficacy in Senior Hypertensives

Condition:   Hypertension
Interventions:   Drug: Aliskiren;   Drug: Amlodipine;   Drug: Ramipril;   Drug: Hydrochlorothiazide
Sponsor:   Novartis Pharmaceuticals
Withdrawn

Wed, 14 Aug 2013 12:00:00 EDT

ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

Conditions:   Hypertension;   Diabetes Mellitus, Type 2;   Albuminuria
Interventions:   Drug: Amlodipine+Benazepril;   Drug: Valsartan+Hydrochlorothiazide
Sponsor:   TSH Biopharm Corporation Limited
Completed

Fri, 17 Jun 2011 12:00:00 EDT

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Conditions:   ASCVD;   Impaired Fasting Glucose;   Hypertension
Interventions:   Drug: Duowell®;   Drug: Monorova® + Amlopin®
Sponsor:   Yuhan Corporation
Completed

Thu, 22 Mar 2018 12:00:00 EDT

Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: Losartan 50mg/amlodipine 5mg;   Drug: Losartan 100mg/amlodipine 5mg;   Drug: Losartan 50mg/Hydrochlorothiazide 12.5mg;   Drug: Losartan 100mg/Hydrochlorothiazide 25mg
Sponsors:   Chong-Jin Kim;   Hanmi Pharmaceutical Company Limited
Completed

Wed, 19 Nov 2014 12:00:00 EST

Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation

Conditions:   Inflammation Plaque, Atherosclerotic;   Coronary Disease;   Renin-Angiotensin System
Intervention:   Drug: 6-month treatment
Sponsors:   CHEOL WHAN LEE, M.D., Ph.D;   Boryung Pharmaceutical Co., Ltd
Completed

Wed, 04 Mar 2015 12:00:00 EST

CKD-828 Primary Hypertension Trial(Dose-selection)

Condition:   Hypertension
Interventions:   Drug: S-Amlodipine, Telmisartan;   Drug: S-Amlodipine;   Drug: Telmisartan;   Drug: Placebo
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Fri, 21 May 2010 12:00:00 EDT

Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)

Conditions:   Heart Failure With Preserved Ejection Fraction;   Pulmonary Disease;   Left Ventricular Hypertrophy/Hypertension
Interventions:   Drug: Dobutamine;   Drug: Amlodipine
Sponsors:   University of Wisconsin, Madison;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Tue, 17 May 2011 12:00:00 EDT

A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Candesartan 8mg;   Drug: Candesartan 16mg;   Drug: Amlodipine 5mg;   Drug: Amlodipine 10mg
Sponsor:   Chong Kun Dang Pharmaceutical
Unknown status

Fri, 01 Aug 2014 12:00:00 EDT

Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

Conditions:   Hypertension;   Dyslipidemia
Interventions:   Drug: Telmisartan + Amlodipine + Rosuvastatin;   Drug: Telmisartan + Amlodipine;   Drug: Telmisartan + Rosuvastatin
Sponsor:   Daewon Pharmaceutical Co., Ltd.
Completed

Fri, 07 Jul 2017 12:00:00 EDT

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

Conditions:   Diabetes Mellitus, Type 2;   Stroke;   Blood Pressure;   Prehypertension;   Cardiovascular Risk Factor
Interventions:   Drug: Allisartan Isoproxil;   Drug: Amlodipine 5mg;   Other: Standard treatment by current guideline
Sponsor:   Jiyan Chen
Recruiting

Tue, 29 Aug 2017 12:00:00 EDT

Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

Conditions:   Hypercholesterolemia;   Hypertension
Interventions:   Drug: Ezetimibe/Rosuvastatin;   Drug: Telmisartan;   Drug: Telmisartan/Amlodipine 80 Mg-5 Mg ORAL TABLET
Sponsor:   Addpharma Inc.
Completed

Fri, 08 Nov 2019 12:00:00 EST

PHARES Study: Management of Resistant Hypertension

Condition:   Hypertension
Intervention:   Drug: irbesartan, amlodipine and hydrochlorothiazide
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed

Fri, 23 Sep 2005 12:00:00 EDT

Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

Condition:   Renal Disorder
Interventions:   Drug: MK0954, losartan potassium/Duration of Treatment: 20 weeks;   Drug: Comparator: amlodipine / Duration of Treatment: 20 weeks
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Thu, 01 Sep 2005 12:00:00 EDT

Spironolactone Versus Indapamide in Obese and Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: Spironolactone;   Drug: Indapamide;   Drug: Amlodipine
Sponsors:   Peking University Third Hospital;   University of Michigan;   Peking University
Unknown status

Mon, 13 Aug 2018 12:00:00 EDT

Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

Conditions:   Renal Insufficiency, Chronic;   Proteinuria
Interventions:   Drug: Lisinopril;   Drug: Amlodipine
Sponsor:   Hospital General Universitario Gregorio Marañon
Recruiting

Thu, 22 Jun 2017 12:00:00 EDT

Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension

Condition:   Hypertension,Essential
Interventions:   Drug: AD209;   Drug: Amlodipine low;   Drug: Amlodipine high;   Drug: Telmisartan
Sponsor:   Addpharma Inc.
Completed

Mon, 06 Jan 2020 12:00:00 EST

Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular

Conditions:   Essential Hypertension;   Diabetes Mellitus
Interventions:   Drug: Losartan;   Drug: Amlodipine
Sponsor:   University of Pavia
Unknown status

Wed, 16 Apr 2008 12:00:00 EDT

Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers

Condition:   Hypertension
Intervention:   Drug: Valsaltan, amlodipine
Sponsor:   Yonsei University
Completed

Wed, 24 Mar 2010 12:00:00 EDT

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Condition:   Hypertension
Interventions:   Drug: HCP1401;   Drug: HCP0605
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Tue, 27 Sep 2016 12:00:00 EDT

The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)

Condition:   Hypertension
Interventions:   Drug: Placebo;   Drug: Comparator: Amlodipine;   Drug: Comparator: ISMN ER
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Tue, 25 May 2010 12:00:00 EDT

A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients

Condition:   Hypertension
Intervention:   Drug: aliskiren
Sponsor:   Novartis
Completed

Thu, 22 Sep 2005 12:00:00 EDT

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

Condition:   Hypertension
Intervention:   Drug: Aliskiren
Sponsor:   Novartis
Completed

Wed, 22 Feb 2006 12:00:00 EST

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

Condition:   Essential Hypertension ( Mild to Moderate)
Interventions:   Drug: Aliskiren;   Drug: Hydrochlorothiazide;   Drug: Amlodipine
Sponsor:   Novartis
Completed

Fri, 03 Oct 2008 12:00:00 EDT

Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

Conditions:   Hypertension;   Cardiovascular Disease;   Diabetes
Interventions:   Drug: olmesartan medoxomil / amlodipine or azelnidipine;   Drug: olmesartan medoxomil / low dose thiazide type drug
Sponsors:   COLM Study Research Organization;   Japan Heart Foundation
Completed

Mon, 02 Apr 2007 12:00:00 EDT

A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg

Condition:   Hypertension
Intervention:   Drug: aliskiren
Sponsor:   Novartis
Completed

Thu, 22 Sep 2005 12:00:00 EDT

Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

Condition:   Hypertension and Dyslipidemia
Interventions:   Drug: Telmisartan;   Drug: Amlodipine;   Drug: Rosuvastatin
Sponsor:   Daewon Pharmaceutical Co., Ltd.
Completed

Fri, 14 Oct 2016 12:00:00 EDT

Effect of Antihypertensive Agents Over Sleep Apnea

Conditions:   Hypertension;   Obstructive Sleep Apnea
Interventions:   Drug: Diuretics;   Drug: Calcium Channel Blockers
Sponsor:   Hospital de Clinicas de Porto Alegre
Completed

Thu, 11 Jul 2013 12:00:00 EDT

Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis

Conditions:   Blood Pressure Variability;   Intracranial Artery Stenosis
Interventions:   Drug: Amlodipine;   Drug: ACEI / ARB;   Drug: Aspirin or Clopidogrel;   Drug: Atorvastatin
Sponsor:   RenJi Hospital
Unknown status

Wed, 15 Aug 2012 12:00:00 EDT

Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance

Conditions:   Insulin Sensitivity;   Aortic Compliance;   Diastolic Function
Interventions:   Drug: Aliskiren;   Drug: Valsartan and Aliskiren;   Drug: Amlodipine
Sponsor:   Brigham and Women's Hospital
Terminated

Thu, 02 Dec 2010 12:00:00 EST

Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome

Condition:   Hypertension
Interventions:   Drug: amlodipine and olmesartan;   Drug: losartan and HCTZ
Sponsor:   InVasc Therapeutics, Inc.
Unknown status

Thu, 06 Jan 2011 12:00:00 EST

The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension

Condition:   Arterial Hypertension
Intervention:   Drug: amlodipine / indapamide / perindopril arginine FDC
Sponsor:   Servier Russia
Completed

Mon, 29 Oct 2018 12:00:00 EDT

Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine

Condition:   Hypertension
Interventions:   Drug: Candesartan cilexetil;   Drug: Olmesartan/Amlodipin
Sponsor:   Institut für Pharmakologie und Präventive Medizin
Completed

Thu, 07 Jun 2012 12:00:00 EDT

Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis

Conditions:   Carotid Artery Stenosis;   Atherosclerosis;   Stroke
Interventions:   Procedure: Carotid Endarterectomy;   Drug: atorvastatin, aspirin, losartan, amlodipine
Sponsor:   Russian Cardiology Research and Production Center
Terminated

Tue, 09 Dec 2008 12:00:00 EST

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: AGSAVI;   Drug: AGLS
Sponsor:   Ahn-Gook Pharmaceuticals Co.,Ltd
Not yet recruiting

Tue, 29 Dec 2020 12:00:00 EST

Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

Condition:   Hypertension
Intervention:   Drug: Amlodipine 10 mg or Losartan 100 mg + Amlodipine 5 mg
Sponsors:   Ullevaal University Hospital;   Merck Sharp & Dohme Corp.
Completed

Wed, 12 Oct 2005 12:00:00 EDT

Blood Pressure Reduction in Heart Failure

Conditions:   Heart Failure;   Cardiac Failure;   Congestive Heart Failure
Interventions:   Drug: Hydralazine/amlodipine;   Drug: Placebo
Sponsors:   University of Sao Paulo;   Conselho Nacional de Desenvolvimento Científico e Tecnológico
Completed

Tue, 07 Dec 2010 12:00:00 EST

Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina

Condition:   Variant Angina
Intervention:   Drug: Placebo
Sponsor:   Korea Otsuka Pharmaceutical Co., Ltd.
Completed

Mon, 03 Oct 2011 12:00:00 EDT

Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

Condition:   Hypertension, Dyslipidemia
Interventions:   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug);   Drug: Olmesartan 40mg, Ezetimibe/Rosuvastatin 10/20mg(Combination drug);   Drug: Amlodipine/Olmesartan 10/40mg (Combination drug)
Sponsor:   Daewoong Pharmaceutical Co. LTD.
Recruiting

Wed, 13 Nov 2019 12:00:00 EST

Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

Conditions:   Hypertension;   Diabetes Mellitus
Interventions:   Drug: Benazepril;   Drug: Losartan
Sponsor:   Hospital Universitario Pedro Ernesto
Completed

Wed, 23 May 2012 12:00:00 EDT

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Condition:   Grade I or II Essential Hypertension
Interventions:   Drug: TAK-536CCB;   Drug: TAK-536CCB + Hydrochlorothiazide;   Drug: Hydrochlorothiazide
Sponsor:   Takeda
Completed

Wed, 26 Feb 2014 12:00:00 EST

Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Hypertension
Interventions:   Drug: Amlodipine/Atorvastatin 5 Mg-20 Mg ORAL TABLET;   Drug: Amlodipine/Atorvastatin 5 Mg-10 Mg ORAL TABLET;   Drug: Allisartan Isoproxil
Sponsor:   Shanghai Jiao Tong University School of Medicine
Recruiting

Tue, 01 Oct 2019 12:00:00 EDT

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

Conditions:   Hypertension;   Dyslipidemia
Intervention:   Drug: Amlodipine/Atorvastatin
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Thu, 08 Sep 2005 12:00:00 EDT

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy

Condition:   Essential Hypertension
Interventions:   Drug: CS8635 20/5/12.5mg and placebo;   Drug: Olmetec® Plus 20/12.5mg and placebo
Sponsor:   Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company
Completed

Wed, 24 Apr 2013 12:00:00 EDT

DP-R212 Pharmacokinetic Study Phase I

Condition:   Healthy
Interventions:   Drug: DP-R212;   Drug: Amlodipine;   Drug: Rosuvastatin
Sponsor:   Alvogen Korea
Unknown status

Mon, 27 Jun 2016 12:00:00 EDT

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Condition:   Hypertension
Intervention:   Drug: valsartan
Sponsor:   Novartis
Completed

Mon, 05 Jun 2006 12:00:00 EDT

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

Condition:   Essential Hypertension
Interventions:   Drug: valsartan/amlodpine;   Drug: losartan/amlodpine
Sponsor:   University of Pavia
Unknown status

Wed, 16 Jul 2008 12:00:00 EDT

Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM

Condition:   Hypertension
Intervention:   Drug: SEVIKAR
Sponsors:   Sang Hyun Ihm, MD PhD;   Daiichi Sankyo Korea Co., Ltd.;   Daewoong Pharmaceutical Co. LTD.
Completed

Thu, 25 Oct 2012 12:00:00 EDT

The SCCS Polypill Pilot Trial

Conditions:   Hypertension;   Hyperlipidemia
Intervention:   Drug: Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)
Sponsor:   Vanderbilt University
Completed

Thu, 30 Oct 2014 12:00:00 EDT

INTERVENCION Trial

Condition:   Blood Pressure, High
Interventions:   Drug: Hydrochlorothiazide;   Drug: Amlodipine;   Drug: Telmisartan
Sponsor:   Prevencion
Unknown status

Thu, 26 Feb 2015 12:00:00 EST

Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis

Condition:   Hypertension
Interventions:   Drug: Losartan + Simvastatin;   Drug: Amlodipine + Simvastatin
Sponsor:   University of Pavia
Unknown status

Wed, 30 Apr 2008 12:00:00 EDT

Vascular Improvement With Olmesartan Medoxomil Study

Condition:   Hypertension
Interventions:   Drug: olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure;   Drug: atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure
Sponsor:   Daiichi Sankyo, Inc.
Completed

Wed, 15 Oct 2008 12:00:00 EDT

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

Condition:   Hypertension
Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5 mg
Sponsor:   George Medicines PTY Limited
Recruiting

Wed, 19 Aug 2020 12:00:00 EDT

Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: ACT-280778;   Drug: Placebo;   Drug: Amlodipine
Sponsor:   Idorsia Pharmaceuticals Ltd.
Completed

Wed, 22 Dec 2010 12:00:00 EST

Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors

Condition:   Hypertension and Cardiovascular Risk Factors
Intervention:   Drug: CADUET (AMLODIPINE 5 mg/ATORVASTATIN 10 mg or 20 mg)
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Terminated

Mon, 24 Dec 2007 12:00:00 EST

Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans

Condition:   Hypertension
Interventions:   Drug: Perindopril plus Amlodipine;   Drug: Perindopril plus Hydrochlorothiazide;   Drug: Amlodipine plus Hydrochlorothiazide
Sponsors:   University of Abuja;   Imperial College London;   University of Cape Town;   Hôpital Edouard Herriot;   University of Nairobi;   University College Hospital, Ibadan;   Hospital General De Douala;   Mulago Hospital, Uganda
Completed

Tue, 19 Apr 2016 12:00:00 EDT

CKD-828(80/2.5mg) Pharmacokinetic Study_2nd

Condition:   Hypertension
Interventions:   Drug: CKD-828(FDC);   Drug: Combination Therapy
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Thu, 12 May 2011 12:00:00 EDT

CKD-828 (40/5mg) Pharmacokinetic Study

Condition:   Hypertension
Interventions:   Drug: CKD-828;   Drug: Combination Therapy
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Fri, 22 Apr 2011 12:00:00 EDT

CKD-828(80/2.5mg) Pharmacokinetic Study

Condition:   Hypertension
Interventions:   Drug: CKD-828(FDC);   Drug: Combination Therapy
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Tue, 23 Nov 2010 12:00:00 EST

Recurrent Stroke Prevention Clinical Outcome Study

Conditions:   Hypertension;   Stroke;   Blood Pressure
Intervention:   Drug: Losartan, Losartan and HCTZ, Amlodipine , Spironolactone
Sponsor:   Biomedis International Ltd.
Unknown status

Fri, 10 Sep 2010 12:00:00 EDT

The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

Condition:   Hypertension
Interventions:   Drug: Amosartan® tab;   Drug: Cozaar® plus pro tab
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Wed, 10 Apr 2013 12:00:00 EDT

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study

Conditions:   Stroke;   Cerebral Small Vessel Diseases;   Intracerebral Hemorrhage;   Vascular Dementia;   Hypertension
Interventions:   Drug: telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg;   Drug: Placebo oral capsule
Sponsors:   The George Institute;   University of Sydney
Terminated

Fri, 21 Dec 2018 12:00:00 EST

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

Conditions:   Intracerebral Haemorrhage (ICH);   Hypertension
Interventions:   Drug: telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg;   Drug: Placebo
Sponsors:   The George Institute;   The University of New South Wales
Recruiting

Fri, 04 Mar 2016 12:00:00 EST

Randomized Controlled Trial of Renal Denervation for Resistant Hypertension

Condition:   Hypertension
Interventions:   Device: Radiofrequency ablation catheter;   Drug: Amlodipine, losartan potassium and hydrochlorothiazide
Sponsor:   Shanghai WiseGain Medical Devices Co., Ltd.
Unknown status

Wed, 14 Sep 2016 12:00:00 EDT

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study

Conditions:   Cognitive Decline;   Intracerebral Hemorrhage;   Dementia, Vascular;   Cerebral Small Vessel Diseases;   Hypertension;   Stroke Hemorrhagic
Interventions:   Drug: telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg;   Drug: Placebo oral capsule
Sponsors:   The George Institute;   University of Sydney
Terminated

Mon, 24 Dec 2018 12:00:00 EST

AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)

Condition:   Abdominal Aortic Aneurysm
Interventions:   Drug: perindopril arginine;   Drug: amlodipine 5mgs;   Drug: placebo
Sponsors:   Imperial College London;   National Institute for Health Research, United Kingdom
Completed

Thu, 06 May 2010 12:00:00 EDT

Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

Condition:   Hypertension
Intervention:   Drug: Telmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mg
Sponsor:   Yuhan Corporation
Completed

Fri, 07 Sep 2018 12:00:00 EDT

Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine

Condition:   JNC 7 Stage 1 or 2 Hypertension
Interventions:   Drug: Nebivolol I;   Drug: Nebivolol II;   Other: Baseline Washout Phase
Sponsor:   Trinity Hypertension & Metabolic Research Institute
Completed

Fri, 17 Aug 2018 12:00:00 EDT

STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)

Conditions:   Hypertension;   Hypercholesterolemia
Intervention:   Other: Treatment algorithm:caduet, Amlodipine, ACEI-ARB combo dose, a-blocker, b-blocker or spironolactone, dyslipidemic therapy with ezetamide
Sponsors:   University of Western Ontario, Canada;   Pfizer
Completed

Mon, 17 Mar 2008 12:00:00 EDT

Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

Conditions:   Hypertension;   Chronic Kidney Disease
Interventions:   Drug: Valsartan;   Drug: amlodipine;   Drug: Hydrochlorothiazide
Sponsor:   Novartis Pharmaceuticals
Completed

Fri, 03 Jun 2011 12:00:00 EDT

Genetics of Hypertension Associated Treatments (GenHAT)

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Coronary Disease;   Myocardial Infarction
Interventions:   Drug: Chlorthalidone;   Drug: Lisinopril;   Drug: Amlodipine;   Drug: Doxazosin
Sponsors:   Donna Arnett, 257-5678;   University of Minnesota;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Tue, 26 Sep 2000 12:00:00 EDT

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: Nifedipine (Adalat, BAYA1040);   Drug: Amlodipine (Norvasc);   Drug: Diovan
Sponsor:   Bayer
Completed

Thu, 26 Jan 2012 12:00:00 EST

Renin Profiling in Selection of Initial Antihypertensive Drug

Condition:   Hypertension
Interventions:   Drug: olmesartan, hydrochlorothiazide, amlodipine;   Drug: hydrochlorothiazide (HCTZ) or olmesartan
Sponsors:   The Louis & Rachel Rudin Foundation;   Daiichi Sankyo, Inc.
Completed

Tue, 03 Feb 2009 12:00:00 EST

Feasibility Study of the Intensive Systolic Blood Pressure Control

Conditions:   Hypertension;   Hyperhomocysteinemia
Interventions:   Drug: Standard BP control;   Drug: Moderate BP control;   Drug: Intensive BP control
Sponsors:   Second Affiliated Hospital of Nanchang University;   Peking University First Hospital
Unknown status

Wed, 29 Jun 2016 12:00:00 EDT

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure

Condition:   Hypertension
Interventions:   Drug: amlodipine and olmesartan medoxomil tablets;   Drug: hydrochlorothiazide tablets
Sponsors:   Daiichi Sankyo, Inc.;   Integrium
Completed

Fri, 14 Nov 2008 12:00:00 EST

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

Conditions:   Aortic Stenosis;   Aortic Regurgitation;   Hypertension;   LVM;   Left Ventricular Hypertrophy
Interventions:   Drug: Amlodipine 5mg;   Drug: Losartan;   Drug: Losartan and Amlodipine;   Drug: Amlodipine/Losartan/Chlorthalidone;   Drug: current treatment
Sponsor:   Hanmi Pharmaceutical Company Limited
Recruiting

Tue, 11 Sep 2018 12:00:00 EDT

ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling

Conditions:   Hypertension;   Left Ventricle Hypertrophy
Interventions:   Drug: Aliskiren;   Drug: Losartan;   Drug: Amlodipine;   Drug: Hydrochlorothiazide (HCTZ)
Sponsor:   Novartis Pharmaceuticals
Completed

Thu, 05 Aug 2010 12:00:00 EDT

Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

Condition:   Hypertension
Intervention:   Drug: valsartan/hydrochlorothiazide
Sponsor:   Novartis
Completed

Thu, 15 Sep 2005 12:00:00 EDT

Lowering Blood Pressure in Primary Care in Vienna

Condition:   Hypertension
Intervention:   Drug: Olmesartan medoxomil, amlodipine, hydrochlorothiazide
Sponsors:   Wilhelminenspital Vienna;   Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology;   Ludwig Boltzmann Foundation for Cardiovascular Research
Completed

Tue, 03 Mar 2015 12:00:00 EST

A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly

Condition:   Hypertension
Interventions:   Drug: Aliskiren;   Drug: Ramipril;   Drug: Hydrochlorothiazide;   Drug: Amlodipine
Sponsor:   Novartis Pharmaceuticals
Completed

Thu, 24 Aug 2006 12:00:00 EDT

Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria

Conditions:   Diabetes;   Hypertensive Disease
Interventions:   Drug: Renin-angiotensin system blockers;   Drug: non-renin angiotensin system blockers
Sponsor:   Hospital Authority, Hong Kong
Unknown status

Wed, 28 Dec 2011 12:00:00 EST

Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

Conditions:   Hypertension;   Hyperlipidemia
Interventions:   Drug: CJ-30061;   Drug: Exforge® 5/160mg & Lipitor® 20mg
Sponsor:   HK inno.N Corporation
Completed

Wed, 05 Sep 2018 12:00:00 EDT

Filtered Trial for Telmisartan 40mg Non-responder

Condition:   Hypertension
Interventions:   Drug: telmisartan+amlodipine;   Drug: telmisartan
Sponsor:   Boehringer Ingelheim
Completed

Tue, 30 Oct 2007 12:00:00 EDT

The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure

Condition:   Hypertension
Interventions:   Drug: Spironolactone;   Drug: Indapamide
Sponsor:   Shanghai Jiao Tong University School of Medicine
Recruiting

Thu, 02 Jul 2020 12:00:00 EDT

Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin

Condition:   Healthy
Interventions:   Drug: amosartan;   Drug: rosuvastatin;   Drug: amosartan and rosuvastatin
Sponsor:   Hanmi Pharmaceutical Company Limited
Unknown status

Fri, 16 May 2014 12:00:00 EDT

Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use

Condition:   Healthy
Interventions:   Drug: T80/A5 mg FDC tablet;   Drug: H12.5 mg tablet;   Drug: T80/A5/H12.5 ng FDC tablet;   Drug: H12.5 mf tablet;   Drug: T80/A5/H12.5 mg FDC tablet
Sponsor:   Boehringer Ingelheim
Completed

Wed, 23 Apr 2014 12:00:00 EDT

Comparison of Optimal Hypertension Regimens

Condition:   Hypertension
Interventions:   Drug: Amlodipine;   Drug: Lisinopril;   Drug: Amiloride;   Drug: Chlortalidone
Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   Medical Research Council
Recruiting

Thu, 28 Jul 2016 12:00:00 EDT

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: LCZ696;   Drug: Amlodipine;   Drug: Hydrochlorothiazide (HCTZ)
Sponsor:   Novartis Pharmaceuticals
Completed

Wed, 08 Dec 2010 12:00:00 EST

OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study

Conditions:   Hypertension;   Cardiovascular Diseases
Interventions:   Drug: Olmesartan medoxomil;   Drug: Calcium channel blockers (amlodipine, azelnidipine)
Sponsors:   OSCAR Study;   Japan Heart Foundation
Completed

Wed, 24 Aug 2005 12:00:00 EDT

Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

Conditions:   Hypertension;   Hyperlipidemias
Interventions:   Drug: CJ-30060;   Drug: Exforge tab 5/160mg, Crestor tab 10mg
Sponsor:   HK inno.N Corporation
Completed

Wed, 04 Jan 2017 12:00:00 EST

Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)

Condition:   Essential Hypertension
Intervention:   Drug: MK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Mon, 12 Sep 2005 12:00:00 EDT

Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine

Condition:   Angina
Intervention:   Drug: Ranolazine
Sponsor:   Gilead Sciences
Completed

Fri, 10 Sep 2004 12:00:00 EDT

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

Condition:   Cardiovascular Events
Interventions:   Drug: Aliskiren;   Drug: Amlodipine;   Drug: Hydrochlorothiazide (HCTZ);   Drug: Placebo for Aliskiren;   Drug: Placebo for Amlodipine;   Drug: Placebo for Hydrochlorothiazide (HCTZ)
Sponsor:   Novartis Pharmaceuticals
Terminated

Tue, 14 Dec 2010 12:00:00 EST

Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome

Conditions:   Hypertension;   Metabolic Syndrome
Intervention:   Drug: VALSARTAN
Sponsor:   Novartis
Completed

Tue, 18 Oct 2005 12:00:00 EDT

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

Condition:   Healthy Male Volunteer
Interventions:   Drug: Exforge®;   Drug: G-0081
Sponsor:   Dong-A Pharmaceutical Co., Ltd.
Completed

Fri, 25 Jan 2013 12:00:00 EST

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

Condition:   Hypertension
Intervention:   Drug: aliskiren
Sponsor:   Novartis
Completed

Thu, 22 Sep 2005 12:00:00 EDT

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use

Condition:   Healthy
Interventions:   Drug: Telmisartan/Amlodipin FDC;   Drug: Telmisartan;   Drug: Amlodipin
Sponsor:   Boehringer Ingelheim
Completed

Fri, 29 Apr 2011 12:00:00 EDT

Fixed-Free HTN Trial

Condition:   Hypertension
Interventions:   Drug: Losartan and amlodipine and hydrochlorothiazide;   Drug: Standard of care
Sponsor:   Hotel Dieu de France Hospital
Unknown status

Thu, 05 Jul 2018 12:00:00 EDT

Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

Condition:   Hypertension(HTN)
Interventions:   Drug: HGP0904;   Drug: HGP0608;   Drug: HGP1405
Sponsors:   Hanmi Pharmaceutical Company Limited;   Seoul National University Bundang Hospital
Completed

Fri, 13 Mar 2015 12:00:00 EDT

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

Condition:   Hypertension
Interventions:   Drug: Valsartan plus Hydrochlorothiazide;   Drug: Candesartan plus Hydrochlorothiazide;   Drug: Amlodipine
Sponsor:   Novartis
Completed

Fri, 04 Aug 2006 12:00:00 EDT

A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension

Condition:   Hypertension
Interventions:   Drug: HCP1803;   Drug: Amlodipine;   Drug: Losartan;   Drug: Placebo
Sponsor:   Hanmi Pharmaceutical Company Limited
Unknown status

Mon, 01 Apr 2019 12:00:00 EDT

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Condition:   Metastatic Triple Negative Breast Cancer
Interventions:   Drug: L-NMMA;   Drug: Docetaxel;   Drug: Amlodipine;   Drug: Pegfilgrastim;   Drug: Enteric-coated aspirin
Sponsors:   Polly A. Niravath, MD;   The Methodist Hospital Research Institute
Completed

Fri, 15 Jul 2016 12:00:00 EDT

PK Study of YH22162 FDC Compared to Combination of Twynsta and Hygroton

Condition:   Hypertension
Interventions:   Drug: YH22162;   Drug: Telmisartan/Amlodipine 80/5 mg (FDC);   Drug: Chlorthalidone 25mg
Sponsor:   Yuhan Corporation
Completed

Tue, 14 Jul 2015 12:00:00 EDT

RAS Peptide Profiles in Patients With Arterial Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Perindopril;   Drug: Olmesartan;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
Sponsor:   University Hospital Inselspital, Berne
Completed

Wed, 20 May 2015 12:00:00 EDT

Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: Lisinopril;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
Sponsor:   The University of Texas Health Science Center, Houston
Completed

Thu, 09 Apr 2015 12:00:00 EDT

Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

Condition:   Pharmacokinetics
Interventions:   Drug: Treatment T;   Drug: Treatment R
Sponsor:   Boryung Pharmaceutical Co., Ltd
Completed

Tue, 14 Aug 2018 12:00:00 EDT

African American Study of Kidney Disease and Hypertension

Conditions:   Hypertensive Nephrosclerosis;   Chronic Renal Insufficiency
Interventions:   Other: MAP goal less than or equal to 92 mm Hg;   Other: MAP goal 102-107 mm Hg;   Drug: Ramipril;   Drug: Amlodipine;   Drug: Metoprolol
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   The Cleveland Clinic
Completed

Mon, 27 Apr 2020 12:00:00 EDT

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

Conditions:   Hypertension;   Diabetes;   Proteinuria
Interventions:   Drug: trandolapril/verapamil;   Drug: Lotrel (amlodipine/benazepril)
Sponsor:   Abbott
Completed

Mon, 10 Oct 2005 12:00:00 EDT

Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

Conditions:   Hypertension;   Left Ventricular Hypertrophy
Interventions:   Drug: Bendroflumethiazide 2.5mg OD; Amlodipine 10mg OD;   Drug: Valsartan 160mg OD; Moxonidine 400mcg OD
Sponsors:   University of Leeds;   The Leeds Teaching Hospitals NHS Trust
Completed

Mon, 20 Aug 2007 12:00:00 EDT

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Condition:   Hypertension
Interventions:   Drug: sacubitril/valsartan (LCZ696);   Drug: olmesartan;   Other: placebo to sacubitril/valsartan (LCZ696);   Other: placebo to olmesartan;   Drug: Amlodipine (Optional)
Sponsor:   Novartis Pharmaceuticals
Completed

Thu, 06 Jun 2013 12:00:00 EDT

The Precision Hypertension Care Study

Condition:   Hypertension
Interventions:   Drug: Zestril®;   Drug: Atacand®;   Drug: Norvasc®;   Drug: Hydrochlorthiazide®;   Drug: Treatment X;   Drug: Treatment Y;   Drug: Placebo
Sponsor:   Uppsala University
Completed

Tue, 17 May 2016 12:00:00 EDT

Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

Condition:   Hypertension
Interventions:   Drug: Twynsta;   Drug: LodineT
Sponsor:   Hanlim Pharm. Co., Ltd.
Completed

Wed, 16 Dec 2020 12:00:00 EST

Valsartan Intensified Primary Care Reduction of Blood Pressure Study

Condition:   Hypertension
Interventions:   Drug: Valsartan and hydrochlorothiazide (HCTZ) - monotherapy;   Drug: Valsartan and amlodipine;   Drug: Usual care;   Drug: Valsartan;   Drug: Valsartan and hydrochlorothiazide (HCTZ) - combination arm
Sponsors:   Novartis Pharmaceuticals;   Baker Heart and Diabetes Institute
Completed

Fri, 15 May 2009 12:00:00 EDT

CKD-828 Telmisartan Non-Responder Trial

Condition:   Hypertension
Interventions:   Drug: CKD-828 40/2.5mg;   Drug: CKD-828 40/5mg;   Drug: Telmisartan 80mg
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Wed, 31 Aug 2011 12:00:00 EDT

Gut Microbiomes in Patients With Metabolic Syndrome

Condition:   Metabolic Syndrome
Interventions:   Drug: Metformin;   Behavioral: lifestyle modification;   Drug: Simvastatin 10mg;   Drug: Amlodipine 5mg
Sponsor:   Chinese University of Hong Kong
Recruiting

Thu, 05 Apr 2018 12:00:00 EDT

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

Conditions:   Hypertension;   Dyslipidemias
Interventions:   Drug: HCP1701;   Drug: Losartan;   Drug: Amlodipine;   Drug: Rosuvastatin and Ezetimibe
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Fri, 30 Aug 2019 12:00:00 EDT

Black Education and Treatment of Hypertension (BEAT HTN)

Condition:   Hypertension
Interventions:   Drug: Hydrochlorothiazide;   Drug: Lisinopril;   Drug: Lisinopril and Hydrochlorothiazide;   Drug: Nifedipine XL;   Drug: Metoprolol tartrate;   Drug: Atenolol;   Drug: Valsartan;   Drug: Doxazosin;   Drug: Clonidine;   Drug: Hydralazine;   Drug: Metoprolol succinate;   Drug: Amlodipine
Sponsor:   Creighton University
Completed

Mon, 21 Apr 2008 12:00:00 EDT

Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly Patients

Conditions:   HIV Infections;   Drug Interactions;   Cardiovascular Diseases
Intervention:   Drug: Co-administration of darunavir with a cardiovascular drug
Sponsor:   Centre Hospitalier Universitaire Vaudois
Completed

Fri, 04 May 2018 12:00:00 EDT

N-of-1 Trials In Children With Hypertension

Condition:   Pediatric Hypertension
Interventions:   Other: NICHE method;   Other: Usual care;   Drug: Amlodipine;   Drug: Lisinopril;   Drug: Hydrochlorothiazide;   Drug: Losartan
Sponsor:   The University of Texas Health Science Center, Houston
Completed

Fri, 09 Mar 2018 12:00:00 EST

Bioequivalence Study of CJ-30060 in Healthy Volunteers

Condition:   Healthy Subjects
Interventions:   Drug: Exforge® tab 5/160mg, Crestor® tab 10mg;   Drug: CJ-30060 5/160/10mg
Sponsor:   HK inno.N Corporation
Unknown status

Wed, 28 Nov 2018 12:00:00 EST

Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

Condition:   Healthy Male Subjects
Interventions:   Drug: Exforge® tab 10/160mg, Crestor® tab 20mg;   Drug: CJ-30060 10/160/20mg
Sponsor:   HK inno.N Corporation
Completed

Tue, 21 Aug 2018 12:00:00 EDT

Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects

Condition:   Healthy
Intervention:   Drug: administration of exforge 10/160mg for 3days. Next 7days administration of exforge 10/160mg and crestor 20mg.
Sponsor:   HK inno.N Corporation
Completed

Tue, 11 Feb 2014 12:00:00 EST

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

Conditions:   HIV Infections;   Cardiovascular Diseases;   Hypertension
Interventions:   Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Amlodipine;   Drug: Diltiazem HCl
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

Thu, 20 Jun 2002 12:00:00 EDT

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

Conditions:   Diabetes Mellitus;   Hypertension
Interventions:   Drug: Losartan 50Mg Tab;   Drug: Losartan/Hydrochlorothiazide 50 Mg-12.5 Mg ORAL TABLET;   Drug: Losartan/Hydrochlorothiazide 100 Mg-25 Mg ORAL TABLET;   Drug: Amlodipine 5mg
Sponsors:   The University of The West Indies;   Caribbean College of Family Physicians
Withdrawn

Fri, 07 Jun 2019 12:00:00 EDT

Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: LCZ696;   Drug: Olmesartan;   Drug: LCZ696 matching placebo;   Drug: Olmesartan matching placebo;   Drug: amlodipine;   Drug: hydrochlorothiazide
Sponsor:   Novartis Pharmaceuticals
Completed

Tue, 25 Sep 2012 12:00:00 EDT

Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment

Condition:   Blood Pressure
Interventions:   Behavioral: phone call;   Drug: amlodipine (calcium chanel blocker) and losartan (at1 antagonist);   Drug: atenolol (beta blocker) and hydrochlorothiazide (diuretic)
Sponsor:   University of Sao Paulo
Unknown status

Tue, 23 Dec 2008 12:00:00 EST

A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

Conditions:   Hypertension;   Pharmacogenetics
Interventions:   Drug: Amlodipine;   Drug: Bisoprolol;   Drug: Hydrochlorothiazide;   Drug: Losartan;   Drug: Placebo
Sponsor:   Helsinki University Central Hospital
Completed

Fri, 08 Sep 2017 12:00:00 EDT

Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

Condition:   Hypertension
Interventions:   Drug: Standard Care;   Drug: Intensive Treatment
Sponsors:   University of Texas Southwestern Medical Center;   Texas Health Resources;   Michigan State University
Recruiting

Mon, 27 Nov 2017 12:00:00 EST

The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy

Condition:   Hypertension
Interventions:   Drug: OROSARTAN® 5/160mg;   Drug: CODIOVAN® 160/12.5mg
Sponsor:   Dong-A ST Co., Ltd.
Completed

Mon, 04 May 2015 12:00:00 EDT

Intensive Vasodilator Therapy in Patients With Essential Hypertension

Conditions:   Essential Hypertension;   High Blood Pressure
Interventions:   Drug: Amlodipine;   Drug: Ramipril;   Drug: Lercanidipine;   Drug: Losartan
Sponsors:   Aarhus University Hospital;   University of Aarhus
Completed

Thu, 12 Aug 2010 12:00:00 EDT

Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet Reactivity

Condition:   Coronary Artery Disease
Interventions:   Drug: Atorvastatin;   Drug: Rosuvastatin
Sponsor:   University of Roma La Sapienza
Unknown status

Fri, 30 Mar 2012 12:00:00 EDT

Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients

Conditions:   Hypertension;   Obesity
Interventions:   Drug: Eplerenone (-based therapy) arm;   Drug: Valsartan (-based therapy) arm
Sponsor:   Hippocration General Hospital
Unknown status

Mon, 26 Mar 2018 12:00:00 EDT

Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up Study

Conditions:   Hypertension;   Diabetes;   Death From Cardiovascular Disease;   Myocardial Infarction;   Stroke
Intervention:  
Sponsors:   Imperial College London;   Pfizer
Completed

Mon, 26 Dec 2011 12:00:00 EST

Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation

Condition:   Hypertension
Interventions:   Drug: Abatacept;   Drug: Placebo
Sponsors:   Vanderbilt University Medical Center;   Bristol-Myers Squibb
Terminated

Fri, 05 Sep 2014 12:00:00 EDT

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Condition:   Hypertension
Interventions:   Drug: Olmesartan medoxomil;   Drug: Hydroclorothiazide;   Drug: Benazepril;   Drug: Amlodipine
Sponsor:   Daiichi Sankyo, Inc.
Completed

Fri, 16 Sep 2005 12:00:00 EDT

Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Volunteers

Condition:   Healthy
Interventions:   Drug: Sevikar(amlodipne/olmesartan);   Drug: crestor(Rosuvastatin)
Sponsor:   Daewoong Pharmaceutical Co. LTD.
Completed

Mon, 17 Mar 2014 12:00:00 EDT

Risk Reduction for Alzheimer's Disease

Conditions:   Cognitively Normal Older Adults;   Hypertension;   Subjective Cognitive Decline;   Family History of Alzheimer's Disease
Interventions:   Drug: Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine);   Behavioral: Aerobic Exercise Training;   Other: Usual Care;   Behavioral: Stretching Exercise
Sponsors:   University of Texas Southwestern Medical Center;   Texas Health Resources;   University of Kansas Medical Center;   Washington University School of Medicine;   Pennington Biomedical Research Center;   Michigan State University
Active, not recruiting

Mon, 26 Sep 2016 12:00:00 EDT

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

Condition:   Hypertension
Intervention:   Drug: T80/A5/H12.5 FDC
Sponsor:   Boehringer Ingelheim
Completed

Fri, 13 Jan 2017 12:00:00 EST

A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension

Condition:   Essential Hypertension
Interventions:   Drug: TAK-536TCH tablet;   Drug: TAK-536CCB tablet;   Drug: HCTZ 12.5 mg tablet
Sponsor:   Takeda
Completed

Wed, 29 Oct 2014 12:00:00 EDT

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

Conditions:   Hypertension;   Cardiac Arrhythmias;   Diabetes Mellitus;   Renal Insufficiency;   Sleep Apnea
Intervention:  
Sponsor:   Elpen Pharmaceutical Co. Inc.
Completed

Thu, 29 May 2014 12:00:00 EDT

A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Condition:   Hypertension
Interventions:   Drug: Cantabell Tab;   Drug: Candemore Plus Tab
Sponsor:   Chong Kun Dang Pharmaceutical
Completed

Thu, 20 Aug 2020 12:00:00 EDT

A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: UI15AML055MT;   Drug: Amosartan 5/50
Sponsor:   Korea United Pharm. Inc.
Completed

Wed, 18 Jun 2014 12:00:00 EDT

Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

Condition:   Hypertension
Interventions:   Drug: Besylsartan;   Drug: Amosartan
Sponsor:   Huons Co., Ltd.
Completed

Wed, 22 Jul 2015 12:00:00 EDT

Evaluation of the Long-Term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension

Condition:   Hypertension
Interventions:   Drug: Nebivolol;   Drug: Metoprolol
Sponsor:   Mylan Bertek Pharmaceuticals
Completed

Fri, 02 Sep 2005 12:00:00 EDT

Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension

Condition:   Hypertension
Intervention:   Drug: Daglutril
Sponsor:   Solvay Pharmaceuticals
Completed

Mon, 12 Sep 2005 12:00:00 EDT

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Conditions:   Type 2 Diabetes Mellitus;   Hypertension
Interventions:   Drug: Placebo;   Drug: Sitagliptin;   Drug: Aprepitant;   Other: Mixed Meal Test (MMT)
Sponsor:   Vanderbilt University
Completed

Mon, 05 May 2014 12:00:00 EDT

Caduet and TLC Intervention in Metabolic Syndrome

Condition:   Metabolic Syndrome
Interventions:   Behavioral: Therapeutic Lifestyle Change;   Drug: Caduet Pill;   Drug: Placebo
Sponsors:   The University of Texas Medical Branch, Galveston;   Pfizer;   University of Texas Southwestern Medical Center
Completed

Fri, 20 Apr 2018 12:00:00 EDT

Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers

Condition:   Healthy Adult Volunteers
Interventions:   Drug: G3041;   Drug: SEVIKAR®
Sponsors:   Dong-A Pharmaceutical Co., Ltd.;   Dong-A ST Co., Ltd.
Unknown status

Mon, 10 Feb 2014 12:00:00 EST

Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

Conditions:   Carotid Artery Stenosis;   Strokes
Interventions:   Drug: Statin;   Drug: Atorvastatin;   Other: Placebo
Sponsor:   Columbia University
Recruiting

Fri, 29 Jul 2016 12:00:00 EDT

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301

Condition:   Hypertension
Interventions:   Drug: AGSAV301;   Drug: Exforge 10/160
Sponsors:   Ahn-Gook Pharmaceuticals Co.,Ltd;   Asan Medical Center
Completed

Wed, 22 Feb 2012 12:00:00 EST

Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients

Conditions:   Hypertension;   Hypercholesterolemia;   Angina Pectoris
Intervention:   Drug: Caduet
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Fri, 27 Aug 2010 12:00:00 EDT

Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF

Condition:   Atrial Fibrillation
Intervention:   Drug: Aggressive Blood Pressure control
Sponsors:   Nova Scotia Health Authority;   Nova Scotia Health Research Foundation
Completed

Wed, 21 Feb 2007 12:00:00 EST

Antihypertensive Treatment in Masked Hypertension for Target Organ Protection

Condition:   Masked Hypertension
Interventions:   Drug: Allisartan Isoproxil;   Drug: Placebo
Sponsor:   Yan Li
Active, not recruiting

Thu, 08 Sep 2016 12:00:00 EDT

Caduet in an Untreated Subject Population

Conditions:   Hypertension;   Dyslipidemia
Intervention:   Drug: Caduet
Sponsor:   Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Completed

Fri, 02 Jun 2006 12:00:00 EDT

A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension

Conditions:   Hypertension;   Plasma Renin Activity
Interventions:   Drug: Hydrochlorothiazide;   Drug: Lisinopril;   Drug: Amlodipine;   Drug: metoprolol;   Drug: lisinopril/hydrochlorothiazide
Sponsors:   University of North Carolina, Chapel Hill;   Cornell University;   Wake Forest University Health Sciences
Completed

Tue, 07 Aug 2012 12:00:00 EDT

Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)

Conditions:   Renal Insufficiency, Chronic;   Nephrotic Syndrome
Interventions:   Drug: Rituximab;   Drug: conventional therapy;   Drug: Mesenchymal stem cells
Sponsor:   Zhujiang Hospital
Unknown status

Thu, 17 Nov 2016 12:00:00 EST

Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers

Condition:   Healthy
Interventions:   Drug: Test formulation;   Drug: Reference formulation
Sponsor:   Severance Hospital
Completed

Thu, 04 Apr 2013 12:00:00 EDT

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population

Condition:   Hypertension
Interventions:   Drug: Aliskiren;   Drug: Hydrochlorothiazide
Sponsor:   Novartis
Completed

Fri, 26 Sep 2008 12:00:00 EDT

Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients

Condition:   Primary Hypertension
Interventions:   Drug: Intensive BP control;   Drug: Standard BP control
Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital
Active, not recruiting

Tue, 10 Jan 2017 12:00:00 EST

Coronavirus (COVID-19) ACEi/ARB Investigation

Conditions:   Hypertension;   COVID-19
Interventions:   Drug: Thiazide or Thiazide-like diuretics;   Drug: Calcium Channel Blockers;   Drug: ACE inhibitor;   Drug: Angiotensin receptor blocker
Sponsor:   National University of Ireland, Galway, Ireland
Suspended

Wed, 01 Apr 2020 12:00:00 EDT

The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

Conditions:   PreDiabetes;   Impaired Glucose Tolerance;   Obesity;   Blood Pressure
Interventions:   Drug: Sacubitril-Valsartan Tab 97-103 MG;   Drug: Valsartan 160mg;   Drug: Placebo Oral Tablet
Sponsors:   Ohio State University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

Mon, 06 May 2019 12:00:00 EDT

ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)

Condition:   Hypertension
Interventions:   Drug: ACEI/CCB;   Drug: ACEI/DIU
Sponsor:   Shanghai Jiao Tong University School of Medicine
Active, not recruiting

Tue, 25 Sep 2018 12:00:00 EDT

Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study

Condition:   Hypertension
Interventions:   Drug: Triatec 10 mg;   Drug: Triatec HCT 5;   Drug: Lasix 25;   Drug: Micardis 80 mg;   Drug: Micardis plus 80/12.5;   Drug: Catapresan TTS 2;   Drug: Norvasc 10 mg;   Drug: Triatec 5 mg;   Drug: Pluscor
Sponsor:   Heart Care Foundation
Completed

Mon, 15 Jan 2007 12:00:00 EST

Non-invasive Haemodynamic Assessment in Hypertension

Condition:   Arterial Hypertension
Interventions:   Drug: lisinopril;   Drug: Telmisartan;   Drug: Nebivolol;   Drug: Indapamide/hydrochlorothiazide;   Drug: Amlodipine
Sponsor:   Military Institute of Medicine, Poland
Completed

Wed, 27 Nov 2013 12:00:00 EST

Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

Condition:   Hypertension
Intervention:   Drug: Micamlo
Sponsor:   Boehringer Ingelheim
Completed

Fri, 13 May 2011 12:00:00 EDT

Medication Adherence and "True" Resistance in Patients With Resistant Hypertension

Conditions:   Hypertensive Disease;   Hypertension, Resistant to Conventional Therapy
Intervention:  
Sponsor:   Charite University, Berlin, Germany
Unknown status

Thu, 01 May 2014 12:00:00 EDT

Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure

Condition:   Hypertension
Intervention:   Drug: Amosartan
Sponsor:   Seoul National University Bundang Hospital
Completed

Mon, 21 Aug 2017 12:00:00 EDT

Adrenal Artery Ablation for Primary Aldosteronism

Conditions:   Primary Aldosteronism;   Hypertension
Interventions:   Procedure: Endovascular chemical Ablation of Adrenal Gland;   Drug: Sequenced antihypertensvie drugs with titrated dosage
Sponsor:   Third Military Medical University
Unknown status

Fri, 31 Aug 2018 12:00:00 EDT

Nephropathy In Type 2 Diabetes and Cardio-renal Events

Condition:   Diabetic Nephropathy
Interventions:   Drug: SoC therapy;   Drug: irbesartan;   Drug: ramipril;   Drug: hydrochlorothiazide;   Drug: furosemide;   Drug: amlodipine;   Drug: atenolol;   Drug: doxazosin;   Drug: clonidine;   Drug: insulin;   Drug: simvastatin;   Drug: fibrate;   Drug: erythropoietin;   Drug: aspirin
Sponsor:   University of Campania "Luigi Vanvitelli"
Completed

Thu, 27 Sep 2007 12:00:00 EDT

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

Condition:   Stroke
Interventions:   Drug: Aspirin / Clopidogrel, Atorvastatin / Simvastatin;   Drug: Asprin / Clopidogrel, Atorvastatin / Simvastatin
Sponsor:   Peking Union Medical College Hospital
Completed

Wed, 23 Apr 2008 12:00:00 EDT

Treatment of Mild Hypertension Study (TOMHS)

Conditions:   Cardiovascular Diseases;   Heart Diseases;   Hypertension;   Vascular Diseases
Interventions:   Behavioral: diet, sodium-restricted;   Behavioral: diet, reducing;   Behavioral: exercise;   Behavioral: alcohol restriction;   Drug: chlorthalidone;   Drug: acebutolol;   Drug: doxazosin;   Drug: amlodipine;   Drug: enalapril
Sponsors:   University of Minnesota;   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

Role of ARNi in Ventricular Remodeling in Hypertensive LVH

Condition:   Hypertensive Heart Disease
Interventions:   Drug: Entresto;   Drug: Valsartan
Sponsors:   National Heart Centre Singapore;   National Medical Research Council (NMRC), Singapore
Recruiting

Tue, 12 Jun 2018 12:00:00 EDT

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

Condition:   Hypertension
Interventions:   Drug: Azilsartan Medoxomil;   Drug: Losartan;   Drug: Placebo for Azilsartan Medoxomil;   Drug: Placebo for Losartan;   Drug: antihypertension medication
Sponsor:   Arbor Pharmaceuticals, Inc.
Completed

Wed, 10 Sep 2014 12:00:00 EDT

Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis

Conditions:   Stroke;   Transient Ischemic Attack;   Atherosclerosis;   Stenosis;   Stents
Interventions:   Device: Stent implantation (Wingspan, Coroflex, and TiTAN2);   Drug: Standard medical treatment
Sponsor:   Peking Union Medical College Hospital
Completed

Thu, 05 Jun 2008 12:00:00 EDT

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

Condition:   Hypertension
Interventions:   Drug: clinical hypertension specialist-no specific med. Any anti-hypertension meds.;   Drug: renin guided therapeutics-no specific med. Any anti-hypertensive med.
Sponsors:   Medical University of South Carolina;   New York Presbyterian Hospital
Completed

Mon, 26 May 2008 12:00:00 EDT

Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension

Condition:   Hypertension
Interventions:   Drug: QUARTET LDQT;   Drug: Candesartan
Sponsors:   Northwestern University;   ACCESS Community Health Network;   University of Sydney
Recruiting

Tue, 21 Aug 2018 12:00:00 EDT

Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics

Conditions:   Hypertension;   Diabetes Type 2
Interventions:   Drug: Aliskiren;   Drug: Hydrochlorothiazide
Sponsors:   William Beaumont Hospitals;   Novartis Pharmaceuticals
Withdrawn

Wed, 14 Oct 2009 12:00:00 EDT

CAndesartan vs LIsinopril Effects on the BRain

Conditions:   Hypertension;   Mild Cognitive Impairment
Interventions:   Drug: Candesartan;   Drug: Lisinopril
Sponsors:   Emory University;   National Institute on Aging (NIA)
Completed

Thu, 14 Nov 2013 12:00:00 EST

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Diabetes Mellitus;   Heart Diseases;   Hypercholesterolemia;   Hypertension;   Myocardial Infarction;   Myocardial Ischemia;   Heart Failure
Interventions:   Drug: Inhibitors, ACE;   Drug: amlodipine;   Drug: lisinopril;   Drug: doxazosin;   Drug: chlorthalidone;   Drug: pravastatin;   Behavioral: diet, fat-restricted
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Thu, 28 Oct 1999 12:00:00 EDT

Default BP Medication Intensification

Condition:   Hypertension
Intervention:   Other: default intensification
Sponsors:   Cedars-Sinai Medical Center;   University of California, Los Angeles
Terminated

Mon, 25 Nov 2013 12:00:00 EST

Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy

Condition:   Coronary Heart Disease (CHD)
Interventions:   Other: Treatment of CHD risk factors;   Drug: Aspirin, Isosorbide mononitrate, Atenolol, Enalapril.;   Procedure: PCA;   Procedure: CABG;   Device: Cardiospec;   Drug: Aspirin, Isosorbide mononitrate, Atenolol, Enalapril
Sponsor:   City Hospital No 40, Saint Petersburg, Russia
Withdrawn

Fri, 29 Jun 2012 12:00:00 EDT

To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults

Conditions:   Hypertension;   Dyslipidemias
Interventions:   Combination Product: ID1803;   Combination Product: ID1801;   Combination Product: ID1803+ID1801
Sponsor:   IlDong Pharmaceutical Co Ltd
Not yet recruiting

Wed, 04 Dec 2019 12:00:00 EST

Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design

Condition:   Hypertension
Intervention:   Other: Evidence-based hypertension treatment
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI);   University of Abuja Teaching Hospital;   Resolve to Save Lives
Recruiting

Fri, 08 Nov 2019 12:00:00 EST

The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

Conditions:   Hypertension;   Metabolic Syndrome
Intervention:   Drug: Aliskerin/Valsartan and Rampiril
Sponsors:   University of Michigan;   Novartis Pharmaceuticals
Withdrawn

Mon, 12 Sep 2011 12:00:00 EDT

Regression of Fatty Heart by Valsartan Therapy

Conditions:   Metabolic Syndrome;   Lipotoxicity
Interventions:   Drug: Valsartan;   Drug: Hydrochlorothiazide
Sponsors:   University of Texas Southwestern Medical Center;   Novartis Pharmaceuticals
Withdrawn

Wed, 03 Sep 2008 12:00:00 EDT

Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas

Condition:   Adrenal Incidentalomas
Interventions:   Procedure: Laparoscopic surgical removal of the adrenal tumor;   Drug: Standardized medical treatment of hypertension by SAHR
Sponsor:   University Hospital, Bordeaux
Active, not recruiting

Mon, 16 Feb 2015 12:00:00 EST

Treating Nocturnal Hypertension and Nocturia in African American Men

Condition:   High Blood Pressure
Interventions:   Drug: Thiazide Treatment Group;   Drug: Intensified Thiazide Treatment Group;   Drug: Combination Medication Treatment Group
Sponsor:   Cedars-Sinai Medical Center
Withdrawn

Tue, 24 Oct 2017 12:00:00 EDT

European Blood Pressure Intensive Control After Stroke

Conditions:   Ischemic Stroke;   Transient Ischemic Attack
Intervention:   Drug: anti-hypertensive
Sponsors:   University College Dublin;   St Vincent's University Hospital, Ireland;   Cork University Hospital;   Tallaght University Hospital;   University of Limerick;   University of Calgary;   Universitaire Ziekenhuizen Leuven;   Attikon Hospital;   Hospital Universitario La Paz;   HRB Stroke Trials Network Ireland;   National University of Ireland, Galway, Ireland;   Mater Misericordiae University Hospital;   University of Oslo;   Newcastle University;   University Hospital Waterford
Not yet recruiting

Mon, 30 Nov 2020 12:00:00 EST

Adrenal Artery Ablation for Uncontrolled Hypertension

Condition:   Uncontrolled Hypertension
Interventions:   Procedure: Selective endovascular chemical ablation of adrenal gland;   Drug: Traditional triple antihypertensive treatment
Sponsor:   Third Military Medical University
Unknown status

Thu, 06 Sep 2018 12:00:00 EDT

Matão Controlling Hypertension (MatCH Study): Rationale and Design

Conditions:   Hypertension;   Blood Pressure
Interventions:   Drug: Captopril 25Mg, Hydrochlorothiazide 25Mg Oral Tablet,;   Drug: Atenolol;   Drug: Losartan potassium 50mg;   Drug: Clonidine
Sponsor:   Centro Neurológico de Pesquisa e Reabiitação, Brazil
Unknown status

Wed, 10 May 2017 12:00:00 EDT

Nutraceuticals and Drug Treatment in Frail Older Adults

Condition:   Frailty
Intervention:   Other: Nutraceuticals
Sponsor:   University of Campania "Luigi Vanvitelli"
Recruiting

Thu, 15 Jul 2021 12:00:00 EDT

Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

Conditions:   Diabetes Mellitus;   Arterial Hypertension
Interventions:   Drug: Metformin;   Drug: Glybenclamide;   Drug: NPH insulin;   Drug: Hydrochlorothiazide;   Drug: Propranolol;   Drug: Captopril;   Drug: Amlodipine
Sponsors:   Hospital de Clinicas de Porto Alegre;   Conselho Nacional de Desenvolvimento Científico e Tecnológico;   Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
Unknown status

Thu, 09 Jul 2009 12:00:00 EDT

The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients

Condition:   Hypertension
Interventions:   Drug: Doxazosin;   Drug: Nifedipine
Sponsor:   First Affiliated Hospital of Harbin Medical University
Unknown status

Wed, 30 Sep 2015 12:00:00 EDT

The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese

Condition:   Hypertension
Interventions:   Drug: metoprolol;   Drug: Nifedipine
Sponsor:   First Affiliated Hospital of Harbin Medical University
Unknown status

Mon, 03 Aug 2015 12:00:00 EDT

Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Condition:   Hypertension
Interventions:   Drug: acetaminophen;   Drug: ibuprofen;   Drug: piroxicam
Sponsors:   University Hospital of Split;   Dr Ivancica Pavlicevic Family Practice Office
Completed

Fri, 07 Mar 2008 12:00:00 EST

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Conditions:   Hypertension;   Type 2 Diabetes Mellitus
Interventions:   Drug: Nebivolol;   Drug: Metoprolol ER;   Drug: HCTZ
Sponsor:   Forest Laboratories
Completed

Fri, 29 Aug 2008 12:00:00 EDT

Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)

Conditions:   Hypertension;   Hypertension Resistant to Conventional Therapy;   Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 Percent
Interventions:   Device: Renal artery Angioplasty plus stenting.;   Drug: Anti hypertensive, statin and antiplatelet medication.
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Ministry of Health, France
Terminated

Thu, 03 Sep 2015 12:00:00 EDT

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

Condition:   Healthy
Interventions:   Drug: HCP1701;   Drug: HCP1306;   Drug: HGP0904;   Drug: HGP0608
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Thu, 26 Mar 2020 12:00:00 EDT

A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

Condition:   Healthy
Interventions:   Drug: HCP1306;   Drug: HGP0904;   Drug: HGP0608
Sponsor:   Hanmi Pharmaceutical Company Limited
Completed

Mon, 09 Sep 2019 12:00:00 EDT

Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

Condition:   Stage D Heart Failure
Interventions:   Drug: Sacubitril-Valsartan;   Drug: Usual care (standard-of-care) arm
Sponsor:   The Cleveland Clinic
Recruiting

Tue, 10 Dec 2019 12:00:00 EST

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

Conditions:   Essential Hypertension;   Cardiovascular Disease;   Stroke;   Chronic Kidney Disease
Interventions:   Drug: Any antihypertensive medication alone or in combination;   Device: Ambulatory blood pressure monitoring
Sponsors:   University of Vigo;   Servicio Gallego de Salud
Completed

Tue, 26 Aug 2008 12:00:00 EDT

Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance

Conditions:   Ischemic Stroke;   Hypertension
Interventions:   Behavioral: Behavioral intensification;   Drug: Pharmacological intensification based on olmesartan;   Device: Bluetooth-equipped sphygmomanometer
Sponsors:   Seoul National University Bundang Hospital;   Daiichi Sankyo Korea Co., Ltd.
Completed

Wed, 18 Jan 2017 12:00:00 EST

Resistant Arterial Hypertension Cohort Study

Conditions:   Hypertension;   Essential Hypertension;   Resistant Hypertension
Interventions:   Drug: chlorthalidone;   Behavioral: motivational intervention for non-compliant individuals;   Drug: standardized anti-hypertensive treatment
Sponsor:   University Hospital, Geneva
Completed

Tue, 09 Mar 2010 12:00:00 EST

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

Conditions:   Atherosclerosis;   Cardiovascular Diseases;   Hypercholesterolemia;   Hypertension;   Diabetes Mellitus, Type 2;   Diabetes Mellitus;   Coronary Disease
Interventions:   Drug: Anti-hyperglycemic Agents;   Drug: Anti-hypertensive Agents;   Drug: Blinded fenofibrate or placebo plus simvastatin
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institute on Aging (NIA);   National Eye Institute (NEI);   Centers for Disease Control and Prevention
Completed

Thu, 28 Oct 1999 12:00:00 EDT

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Conditions:   Hypertension;   COVID
Interventions:   Drug: ACEI/ARB;   Drug: Non-ACEI/ARB;   Drug: ACEI;   Drug: ARB
Sponsors:   University of Utah;   VA Salt Lake City Health Care System;   University of Pennsylvania;   Wake Forest University Health Sciences;   University of Florida;   Johns Hopkins Bloomberg School of Public Health;   Boston University;   Northwestern University;   Edith Nourse Rogers Memorial Veterans Hospital;   Columbia University;   MedStar Georgetown University Hospital
Completed

Mon, 13 Jul 2020 12:00:00 EDT

Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors

Conditions:   Delirium;   Anesthesia; Adverse Effect
Interventions:   Procedure: Types of Anesthesia;   Procedure: Access of Surgery;   Other: Comorbidities;   Drug: Preoperative Medication;   Diagnostic Test: Routine blood test
Sponsor:   Sultan Qaboos University
Completed

Thu, 30 May 2019 12:00:00 EDT

Analyzing How Genetics May Affect Response to High Blood Pressure Medications

Conditions:   Hypertension;   Coronary Disease;   Cerebrovascular Accident
Intervention:  
Sponsors:   University of Alabama at Birmingham;   National Heart, Lung, and Blood Institute (NHLBI);   University of Texas;   University of Minnesota
Completed

Mon, 26 Nov 2007 12:00:00 EST